MEDR Wellness
   4126 Sherwood Way
 San Angelo, TX 76901
    1-877-390-6337

Welcome to our MEDR Library

1. Health Trends and Challenges:
2. Why we have so much disease
3. Restoring Health
4. Castor Oil Packs
5. Stepping Up To Better Health
6. ***NEW*** Indigestion
7. Removing Gallstones Naturally
8. Fig Paste
9. Parasites throughout history
10. Colds and flu
11. Lymphatic Exercises
12. Iridology
13. GSE (Grapefruit seed extract)
14. Garlic Drink
15. Food Chart
16. References

Health Trends and Challenges:

Contributing Factors

• Farming Practices and Erosion => incomplete foods
• Processed foods (food stuff) => incomplete foods
• Genetically Engineered Foods => alters makeup
• Synthetic Foods/Chemical Additives => toxic
• Environmental toxins
• CoFactors: Contributors to health challenges (viruses, bacteria, yeast/fungus, and parasites)
• Lack of Knowledge

Cancer

• v1900: 1 in 30 Americans
• v1980: 1 in 5 Americans
• v1990: 1 in 4 Americans
• v1995: 1 in 3 Americans
• v2000: 1 in 2 Americans
• v2010: projected to be 1 in 1

Heart Disease

• 58 Million have High Blood Pressure
• 39 Million are under age 65
• 1.5 Million Heart Attacks each year
• 1/3 do not survive
• 0.5 Million Strokes each year
• The Number One cause of death is Heart Disease

Osteoporosis

• 1900 ® practically non-existent
• Today 24 + million
• 1.5 million fractures annually
• High % die within 6 months

Type II Adult Onset Diabetes

• 1900 non-existent & within last 10 years > doubled
• Now 18.2 million (6.3%) 13 million diag. 5.2 million non diag.
• 1.3 million diagnosed / year
• Went from 1,300 –> 3,561 newly diagnosed daily
• Doubles risk of premature death
• Increases risk of cardiovascular disease 200-300%
• Believed to be 100% nutritionally based

Arthritis

• 1900 rare occurrence
• Today 43 + million

Why we have so much disease.

It is plain and simple: because we have gotten away from consuming what our creater has provided for us and MAN'S GREED!

See Scriptural References

So where do I start?: A good place to start is from the beginning, from a foundational approach.

“Where do I start” for health improvement to re-establish solid health is an age old question that is a legitimate question and often concern. Whenever building anything, the most important aspect to consider is the foundation because if the foundation is weak, the whole structure will be vulnerable or become weak and not last. This applies to any structure, whether it is a building or a body.

With this in mind, how does this foundational approach apply to our bodies? Let’s look at nature who was the original provider for nutritional support. The foods that were originally available, were wholesome, complete and clean in being not contaminated. This is no longer the case. Commercial farming practices have stripped the land of vital and essential nutrients for the foods that are grown on them to be wholesome and complete. Because the foods are less sturdy and complete, they are subject to damage from natural predators and they are therefore heavily sprayed with chemical pesticides fungicides and herbicides that also contaminate our foods. Many of our foods are highly processed, which leaves them lacking or void in phytonutrients (nutrition from plants), many of which have not yet been discovered. This may be good for shelf life, but it is insufficient for our bodies.

All of these factors have contributed to the erosion of our nutritional foundation. Many products have been produced as well as many approaches to effectively address this need. Some of these have provided the necessary support and produced health benefits, but how does one know by how much and is it sufficient to meet all of the bodies needs?

First of all, whole food based supplementation is the most compatible with filling the voids that exist in our real foods as well as the processed ones. Whole food based nutrient support is more efficient and effective in helping meet the body’s nutritional needs, and if for no other reason that it comes closer to meeting what nature intended for us to have and use to support our health. Also synthetics adds stress to the body as it deals with them and the end result of what is actually utilized is reduced and most of the time dramatically reduced.

Even when the best supplements are utilized, the questions still exists: Is my body actually getting what it needs to effectively support health as well as address all of it’s health challenges; How do I know what to take; and How much do I need? These are all excellent questions that have a simple, but not always obvious answer. It is to ask your body questions and listen to the answers.

You may say, How do I do that? Our body is constantly talking to us in the ways of how we feel, how we function, how we think, and how we react. These are signs of symptoms. They can be good or bad, depending what is going on inside of us. When we start practicing being aware of our body’s talk, we are listening and learn what our body is trying to tell us. If we listen carefully, it can make a big difference, one that could even save our life at times.

There are some specifics involved. They include making ourselves disciplined enough to observe our body’s responses to the nutrition that we provide it, learning what symptoms are associated with what nutrients and potential deficiencies, making a daily diary of our health symptom wise, analyzing the results, and supplementing in the areas that appear to be deficient. Our body will tell us long in advance of health problems that are brewing and if we listen and react accordingly, we will be able to obtain as well as maintain health and wellness.

If this appears to be too much there are alternatives such as finding a good consultant and hope that they are competent enough to effectively address all of your needs or find a program, either in written or electronic form, that assists in monitoring and analyzing your health status from information obtained from the absolute best consultant for you – YOU. Additional information that would be helpful is to obtain a source or list of healthy foods and the average amounts of nutrients in them so that you can focus on the foods highest in the nutrients that your body is telling you it needs to meet your daily requirements.

You may say that this seems like a lot, but it pays big dividends to those who can effectively accomplish using this technique, that of listening to what your body is saying and then reacting accordingly. After all the best consultant who should have the most interest in your health is you and when you achieve this taking control of your own health, you are the one who is able to benefit the most. For all who heed this and apply it to their life, I commend you and welcome you to the elite group of healthy and stay healthy people. It is a very good group to be a part of.

Healthfully yours, Dr. J. Michael Ernest

Restoring Health

• Neutralize Free Radicals
• Address specific nutritional deficiencies
• Revitalize Immune System
• Detox: the ABC’s of Health
• Support with Foundational Nutrition (whole Food based)
• Consume Live Whole Foods
• Adopt a Life Style supporting Wellness
• Positive Mental Attitude

Co-Factors are anything that obviously contributes to the deterioration of ones health, and is directly involved in poor health, health challenges and diseases.

Co-Factors can include: Toxins, Chemical Additives in foods and food stuff (processed and not in its natural form), Empty and/or imbalanced Foods, and unhealthy Life Styles.

Even Normal Metabolic Function can produce more Free Radicals then available antioxidants to neutralize them resulting in premature aging and harm to health.

Toxins

• 390,000 tons of Pesticides are used each year = 3 pounds per each person in USA.
• 90% fungicides, 60% herbicides, and 30% insecticides have been shown to cause cancer in animals.
• Steroids, hormones, antibiotics, and ingested contaminants are in our meats.

Hollow imbalanced foods are causing: "Our bodies to be well fed, yet at the same time to be starving for nutrition. We are not starving ourselves to death. We are eating ourselves to disease and then to death."
- Dr. J. Michael Ernest 2001

Healthy Foods and Tips

• Live Foods: eat some with every meal
• Butter is better then margarine
• Good Eggs lower cholesterol
• If consume dairy: take Vitamin C and Folic acid
• Use sea salt and cayenne (red) pepper
• Healthy snacks: Fruit, nuts, seeds, carrot & celery sticks
• Ideal weight reduction: eat 4-6 small healthy meals/day and include adequate supplementation
• Drink 6-8 eight oz glasses of good water/day
• Best source for calcium and other minerals: Vegetables

Castor Oil

Directions

1. Only use cold pressed Castor Oil.
2. Apply about ½ oz of Castor Oil to a piece of flannel (cotton or wool) about 4 in X 4 in to 4 in X 6 in. or a 4 X 4 sterile gauze pad (do not soak cloth).
3. Cover desired area (center of abdomen for lymph → pyers patch) or other area of concern [knee] from swelling, damaged tissue or to assist lymph function.
4. Place plastic over the cloth, cover with heating pad or hot water bottle or other source of heat (can do without heat, but it enhances healing/cleansing).
5. Leave on for 30-45 minutes (can leave on over night if desired).
6. Remove and can cleanse with distilled water, no soap or chemicals.
7. Repeat as needed or deemed necessary.

Thyroid Area

1. Take equal amounts (about ¼ oz of each) of castor oil (cold pressed) and aloe vera gel and mix together
2. Add 1/2 teaspoon of powdered ginger, mix and place on a 4 X 4 in gauze.
3. Place it over the thyroid area (mid center of throat), then cover with plastic, then a heating pad on medium for 30 minutes.
4. Do this for 1 X / week for 2 months, then 1 X / month.

Thymus Area

1. Apply approximately 1/2 oz of castor oil (cold pressed) to a 4 X 4 in gauze.
2. Place it over the thymus area (mid center of chest), then cover with plastic, then a heating pad on medium for 30 minutes.
3. Do this for 1 X / week for 2 months, then 1 X / 6 months.

Castor Oil / Aloe Pack

1. Take equal amounts (about ¼ oz of each) of castor oil (cold pressed) and aloe vera gel and mix together and place on a 4 X 4 in gauze.
2. Place it over the thymus area (mid center of chest), then cover with plastic, then a heating pad on medium for 30 minutes.
3. Do this for 1 X / week for 1-2 months.

Pyers Patches Area

1. Apply approximately 1/2 oz of castor oil (cold pressed) to a 4 X 4 in gauze.
2. Place it over the lower mid area of the abdomen, then cover with plastic, then a heating pad on medium for 30 minutes.
3. Do this for 1 X / week for 2 months, then 1 X / month.

Castor/Aloe Pack

1. Take equal amounts (about ½ oz of each) of castor oil (cold pressed) and aloe vera gel and mix together and place on a 4 X 4 in gauze opened to 4 X 8 in.
2. Place it over the lower mid area of the abdomen, then cover with plastic, then a heating pad on medium for 30 minutes.
3. Do this for 2 X / week for 2 months, then 1 X / month.

Stepping Up To Better Health

The first step: increase the amount of cooked vegetables you eat each day. For many people, one serving a day of any vegetable is a dramatic increase.

The second step: reduce the amount of protein foods you eat each day. Have smaller servings of beef, poultry, or fish as you continue to add more cooked vegetables to your meals.

The third step: cook the vegetables less and include one serving of raw vegetables or fruit every day.

The fourth step: begin to reduce your intake of salt, caffeine (coffee, tea, soft drinks) and processed (fabricated) snack food.

The Ideal Percentages of Foods 45% cooked fruits and vegetables; 30% raw fruits and vegetables; and 25% grains, nuts, seeds, meat, fish, or poultry.

Protein in our Diet

The ideal amount of protein consumed daily should be between 15-30 grams, depending upon your activity level and if it is more than 2 times that of an average persons, then your consumption should be up to 30-45 g of protein per day

as increasing proportionally the amount of complex carbohydrates and fatty acids to 1 ½ to 2 times average.

Time to restore pH Balance and Normal Body Functioning Under ideal conditions: six months to a year.

Meals

Morning meal: eat fruit (it is cleansing), then if need to eat more, wait 15-20 minutes before consuming additional food.

Lunch: Vegetables, salads, grains, little to no high protein (meats, eggs, fish, dairy OK but small serving.

Dinner: Vegetables, salads, eggs, small serving meat 4-6 oz, dairy (cheese, cottage cheese, yogurt, etc) if have starches do not have high protein food.

Snacks

Eat only one kind or group of food at a time. Celery, carrots, raisins, fruit, grain (bread, bagel, toast, etc. Afternoon or evening (higher in protein): nuts, seeds, hard boiled egg.

Do not mix starches with high protein foods, do not mix fruits with starches, melons should be eaten alone, do not mix protein with sweet fruits or sugar, BEGIN each meal with something raw (starts enzyme metabolism) Little to no liquids with meals (dilutes digestive juices – liquid is in fruit and vegetables). Fruit best for first meal, protein best for last meal.

Indigestion

• By eating green ginger salad adding in it a pinch of rock salt-common salt before meal, cures indigestion. You also feel hungry.
• Indigestion is cured by licking mixture of mint juice and sanchal.
• By drinking a mixture of 1/2 tsp bishop weed seed, a pinch of rock salt-common salt in lemon juice, cures indigestion.
• By mixing 1 tsp green ginger juice and 2 tsp honey in a glass of warm water and by drinking this water cures indigestion.
• If you don't feel hungry at all then by eating 1/2 tsp bishop weed seed twice a day after chewing it properly will make you feel hungry.
• By taking mustard seed powder along with water cures indigestion.
• Cut ripe pineapple into pieces, sprinkle pepper and rock salt on it and eat it to cure indigestion.
• Mix 1 tsp lemon juice, 1 tsp green ginger juice and a pinch of rock salt-common salt togather and drink it to cure indigestion.
• Cut a lemon, sprinkle rock salt-common salt on it and suck it before having meal to cure indigestion
• By taking equal quanity of gram and asafetida along with ghee cures indigestion.
• Take equal quanity of dry ginger, pepper, long pepper and rock salt-common salt and make a powder of it. By taking this powder in butter milk cures indigetsion.
• By drinking onion juice mixing in it roasted asafetida cures swelling of belly.
• By eating garlic buds seasoned in oil or by eating garlic ketchup, cures tastelessness - inactivity.
• Make a decoction of mangosteen by adding ghee in it and drink it to cure indigestion.
• Mix equal quanity of garlic, sugar and rock salt-common salt, mix double the quantity of ghee and eat it to cure indigestion and swelling of belly.
• Heat a tomato slightly, sprinkle sindhalun (powdered rock salt) and sea salt on it and eat it to cure indigestion.

Removing Gallstones Naturally

by Dr Lai Chiu-Nan

It has worked for many. If it works for you please pass on the good news. Chiu Nan is not charging for it, so we should make it free for everyone. Your reward is when someone, through your word of mouth, benefits from the regime. Gallstones may not be everyone's concern. But they should be because we all have them. Moreover, gallstones may lead to cancer. "Cancer is never the first illness," Chiu Nan points out. "Usually, there are a lot of other problems leading to cancer.

In my research in China, I came across some materials which say that people with cancer usually have stones. We all have gallstones. It's a matter of big or small, many or few.

One of the symptoms of gallstones is a feeling of bloatedness after a heavy meal. You feel like you can't digest the food. If it gets more serious, you feel pain in the liver area." So if you think you have gallstones, Chiu Nan offers the following method to remove them naturally.

The treatment is also good for those with a weak liver, because the liver and gallbladder are closely linked.

Regimen:

1. For the first five days, take four glasses of apple juice every day. Or eat four or five apples, whichever you prefer. Apple juice softens the gallstones. During the five days, avoid all oils, fats, fried foods, etc. Eat as much vegetables and fruit as possible.
2. On the sixth day, take no dinner.
3. At 6 PM, take a teaspoon of Epsom salt (magnesium sulphate) with a glass of warm water.
4. At 8 PM, repeat the same. Magnesium sulphate opens the gallbladder ducts.
5. At 10 PM, take half cup olive oil (or sesame oil) with half cup fresh lemon juice. Mix it well and drink it. The oil lubricates the stones to ease their passage.

The next morning, you will find green stones in your stools. "Usually they float," Chiu Nan notes. "You might want to count them. I have had people who passes 30, 50 or up to 100 stones. Very many."

"Even if you don't have any symptoms of gallstones, you still might have some. It's always good to give your gall bladder a clean-up now and then.

Recipe for Fig Paste

• Take 1 cup of finely chopped mission figs and place into sauce pan,
• Add 1/2 cup water, mix and heat on low,
• Simmer until mixed well and liquefied (about 3-5 minutes),
• Add 1/4 cup corn starch and 2 TBL honey and mix while cooking on low heat,
• Cook for 10 minutes, stirring occasionally,
• Remove from heat and let cool,
• Place covered in refrigerator.
• Take 1 - 2 tablespoons per day.
• [Note can double, triple, etc amounts if have enough ingredients]

Parasites throughout history

Acts 12:23 The angel of the Lord smote him. Josephus says he lingered five days in great agony (This harmonizes with Luke's account). He was eaten of worms. Josephus says he was taken with abdominal pains; Luke explains the cause. The disease is by no means unknown. Many cases of death from the same cause are on record. Among others the Emperor Galerius, the predecessor of Constantine the Great, so died.

Cold and Flu

1. Gargle with hot salt water 3-5 times a day. To 4 ounces of water, as hot as can gargle with, add ½ teaspoon of sea salt, stir and gargle several times till all water is used.
2. If you have or can get a nasal spray bottle (can get one at store with saline in it for 1-2 dollars). If have empty one add some saline (to make saline add 1 teaspoon sea salt to 8 ounces of good water) Spray several times in each nostril while breathing in through nostrils (to cleanse whole area well), then blow nose to eliminate excess fluids. Do this 2-3 times a day until no longer needed.
3. Place several drops of colloidal silver in each nostril 2-3 times. Do at times different from the saline spray, at least 5 – 10 minutes after.
4. Spray (or squirt several droppers) of colloidal silver into the back of the throat several times a day (3-5 times)
5. Get Vitamin C with zinc lozenges and suck on them throughout the day (3-5 / day)
6. Get a cool mist humidifier (if you do not already have one – can get at Walgreen’s or WalMart or Price Right etc.) and add 8 ounces of colloidal silver to a gallon of distilled water and also add 5-7 drops of GSE (Grapeseed extract). Run this at night next to where you sleep and can breathe mist. Do this for 1 hour each night for 2-3 days.
7. If you can get it, get AlliBiotic by NOW and take 2 - two times a day for 2-3 days and then 1 / day for a week.
8. If have transfer factor, take 3 / day for 3 days.
9. Acidophilus, take 2-3 times the suggested amount for a week
10. Castor oil packs, one over the throat and one over the abdomen (see directions) Can do both at one time or separately. Do 1 / day for 2-3 days.
11. If taking a herbal bowel stimulant [FBS] (herbal tab, etc take an extra one and if not taking any, take 1 FBS at night for 2-3 days.
12. Take 3-4 FICS in AM for 3 days in a row
13. Think lots of happy thoughts and pray for as many other people as you can for three days straight.
14. Do all of these and you should not have any cold or flu within 3 days and you will be so busy dealing with doing these that it will go so fast you won’t realize that you had the cold.

Lymphatic Exercises

To start do a neck roll keeping your head as close to your body as possible. Roll in one direction 3 times and then in the other direction 3 times.

Next, massage your lymph vessels, using a ball, jar, or similar item. Start at the upper chest and breast area, work under each arm up to the elbows, continue down the abdomen, especially the center (a network of lymph are there), continue down in the groin areas and down to the knees. Apply a moderate amount of pressure when massaging.

Next, bounce on heels on a hard surface. Bounce 20 times.

Then bounce 10 times on either a trampoline or couch or bed. To bounce on a couch or bed, get on it on your knees to bounce.

Note: to stimulate the lymph during the day, occasionally take a long deep breath or take 3 short quick hard breaths and 1 long deep one. This is excellent for stimulating the lymph. Also get adequate rest, which is when the lymph system does its major cleansing.

Iridology

Iridology is the scientific analysis of patterns and structures in the iris of the eye locating areas and stages of inflammation throughout the body. The iris is the colored portion of the eye. It reveals body constitution, inherent strengths and weaknesses health levels, and transitions that take place in a person's body according to their way of life.

Like most Western healing arts, iris diagnosis literature cities Hippocrates as an original practitioner. Its early history also includes trainings in iris diagnosis at the Medical School of Salerno. A 1630 book, Chiromatica Medica, notes that signs in the iris indicate diseases.

Author Philippus Meyens believed that the condition of the heart and spleen could be read in the left iris, the liver on the right. And, on a non-scientific level, people have always looked into the eyes of their fellow humans-and other animals-to determine feelings and physical well-being. Shepherds, for example, have long examined their sheep's eyes to cull the week ones from the flock.

The mythical origin of modern iridology credits a Hungarian physician, Dr. Ignaz von Peczely. As a boy struggling with a captured owl, Peczely broke its leg. He noticed a dark spot appear just then in its eye. This incident was supposed to have inspired Peczely to pursue his study of injuries and iris marks as a medical student and surgical intern.

After several decades of comparative study, he developed an iris topology. Superimposing a clock face over drawings of the eyes, he mapped organs across zones identified by hours and minutes. In 1881, Peczely published his theories in Discoveries in the Field of Natural Science and Medicine: Instruction in the Study of Diagnosis from the Eye.

Soon after, Swedish doctor Nils Liliequist added his observations on color changes. He was the first to identify the effects of drugs, such as iodine and quinine, on the iris.

One of his students, Dr. Henry Lahn, brought the practice of iridology to America near the turn of the century. A naturopath and chiropractor, Bernard Jensen has been America's foremost proponent of iridology. He is currently setting up a research center, creating a computerized eye bank, analyzing the irises of hundreds of heart and kidney patients. Each case is catalogued with its correlating iris signs information; Jensen hopes this will aid in standardizing iridology interpretations. Jensen developed one of the most comprehensive iris charts showing the location of the organs as they reflex in the iris of the eye. His chart is still the most accurate one available today.

A complete iris analysis will show whether a person exhibits a generally good constitution or a poor one, depending upon the density of the iris fibers. The patterns, structures, colors, and degrees of lightness and darkness in the iris tell if an area of the body is inherently strong or weak and reveals the relative state of activity, irritation, injury, or degeneration of the tissues and organs. Toxic accumulation levels can be observed as well as nutritional and chemical imbalances. Favorable changes, in the form of healing lines, are also recorded in the iris.

Iridology will not show or name a specific disease but provides information about the body tissues which indicate tendencies toward or away from conditions of 'dis-ease' often before symptoms appear. Iridology will not reveal surgery performed under anesthesia as nerve impulses are discontinued. Iridology cannot locate parasites, gallstones, or germ life, but will indicate the presence of inflammation and toxic conditions which are a refuge for their development. It will not show pregnancy, as that is a normal function of the female body.

Grapefruit Extract

What is It?

Grapefruit Extract(GSE) is made by first converting grapefruit seeds and pulp into a very acidic liquid.

This liquid is loaded with polyphenolic compounds, including quercitin, helperidin, campherol glycoside, neohelperidin, naringin, apigenin, rutinoside, poncirin, etc. The polyphenols themselves are unstable but are chemically converted into more stable substances that belong to a diverse class of products called quaternary ammonium compounds.

Some quaternary compounds, benzethonium chloride and benzalkonium chloride, for example, are used industrially as antimicrobials, but are toxic to animal life. The B vitamin choline is also a quaternary compound, but is non-toxic and even essential for maintaining healthy neurological function and fat metabolism.

GSE features the best of both worlds: the quaternary compounds derived from grapefruit exhibit broad-spectrum antimicrobial activity, while evidencing none of the toxic side-effects of chemically-derived quaternaries.

The finished product is a viscous, yellow-amber colored liquid that features a taste that is both bitter and acidic. (Practitioners of Chinese and Ayurvedic medicine consider both qualities to be part of the therapeutic process.) Pure vegetable glycerin is added to reduce the bitterness and acidity to a tolerable level and to reduce the possibility that incidental contact could cause irritation to the skin or mucous membranes.

Grapefruit Extract Production

1. Grapefruit pulp and seeds(the by-product of expeller-extracted grapefruit juice) is dried and ground into a fine powder.
2. The grapefruit powder is dissolved in purified water and distilled to remove the fiber and pectin.
3. This distilled slurry is spray dried at low temperatures forming a concentrated grapefruit bioflavonoid powder.
4. This concentrated powder is dissolved in vegetable glycerine and heated.
5. Food grade ammonium chloride and ascorbic acid are added, and this mixture is heated under pressure.
6. This material undergoes catalytic conversion using natural catalysts (including hydrochloric acid and natural enzymes).
7. This slurry is cooled, filtered and treated with ultraviolet light.

The amount of Ammonium Chloride remaining in the final product is between 15% and 19%. The amount of Ascorbic Acid remaining in the final product is between 25mg/g and 30mg/g. There is no residue of hydrochloric acid in the final product.

How Does it Work?

It should come as no surprise that we know a lot more about what GSE is good for, than exactly how it works.

Take aspirin. Since its development in 1899, billions of people have benefited from its ability to reduce inflammation, lessen pain, and lower fever. But exactly how it works is only recently being better understood.

Fro Seoul, Korea, Dr. Sung-Hwan of Abcom Chemie Co., Ltd states:

"Considering all the electron micrographs, we believe that the microbial uptake of GSE alters the cell membrane by inhibiting enzymatic activities… You can see the loss of the cytoplasmic membrane."

What is not known is how GSE can affect the cell membranes of such a diverse group of microbes with virtually no toxicity toward animal life(The "Acute Oral Toxicity Study" performed by an independent laboratory concluded that you would have to take 4,000 times the normal adult dose to risk a 50% chance of poisoning). And to complicate matters further, since viruses do not have a cell membrane of their own, how is it that GSE can act as an antiviral remedy as it does?

Unraveling the mysteries of GSE and its mechanisms would undoubtedly provide extremely valuable insight into the basic activity of microbes. We might hope that research funds will become available to answer the many questions raised about how it can be so potent and yet so safe.

How was GSE Discovered?

Jacob Harich was eating a grapefruit for breakfast one morning in France and savoring its taste.

World War II had just ended and since fresh fruit was a rare treat in Europe at that time, Jacob savored it all the more - until, that is, he bit into a seed! The extremely bitter taste of the seed interrupted his enjoyment of breakfast but also prompted him to wonder, 'What makes it so bitter?'

For many, such a question would have been of mere passing interest, but for Jacob, a budding scientist, it inspired a compelling inquiry, one that would take decades to answer and years more to 'bear fruit'.

Jacob Harich was born in Yugoslavia in 1919 and educated in Germany. WWII interrupted his studies in nuclear physics. After witnessing the horrors of war as a fighter pilot, young Harich was inspired to devote the rest of his life to improving the human condition. To this end, he augmented his studies in physics with a full university course in medicine, specializing in gynecology and immunology. Arriving in the United States in 1957, Dr. Harich furthered his education at Long Island University, N.Y. But it wasn't until 1963, after moving to the heart of grapefruit country in Florida, that he received the necessary support to carry out his research.

Harich approached Dr. Steven Otwell and Dr. Wayne Marshall, both leading researchers on the effects of microbes on food. Although initially skeptical, they were won over by the demonstration of GSE's amazing ability to protect produce, fish, and poultry from the assault of bacteria, fungi, and parasites. The reputation of these two doctors and the renown of the food science laboratory at the University of Florida, Gainesville, their home base, prompted other institutions to consider the claims being made by Dr. Harich.

Finally, by 1990, holistic health practitioners in the United States began to hear about this remarkable product and understand the implications for their patients. This in turn, gave Dr. Harich's work the boost it deserved as well as added to the scientific credibility of its potential benefits.

In 1995 Dr. Harich was invited to Europe as a guest of honor of the Pasteur Institute of France, Europe's leading AIDS research center. For several years the Institute has been researching the potential of GSE as a prophylactic against the HIV virus as well as against some of the secondary infections associated with AIDS. He was also honored by farmers in Europe who now use a powdered form of GSE in fish and poultry feed to fight two potentially lethal bacteria, Salmonella and E. Coli.

Dr. Harich died in May of 1996. It is pleasant to think that he did receive in his lifetime the recognition he deserved for a life devoted to a revolutionary approach to controlling dangerous germs.

Garlic Drink Directions

Directions for taking any liquid nutritional support in a garlic drink daily for enhanced benefits.

Garlic drink: To a blender add 1 – 2 cloves of peeled garlic, 4-6 oz juice (e.g. V8, tomato, etc., not from a can), add any liquids currently taking), 1 TBL cold pressed organic oil such as olive or sunflower etc., OR 1 - 2 teaspoons of vegetable based oil and 1 teaspoon of cold pressed Castor Oil, blend to liquefy, add 2 – 4 more oz juice, blend and drink in AM on an empty stomach.

Garlic Drink Liver cleanse

To 8 ounces of hot good water, add 1-2 crushed cloves of garlic, the juice of ½ lemon (fresh squeezed) 1 teas of olive oil, and ¼ - ½ teas powdered cayenne (or 3-5 drops of the tincture). Mix well and drink. Within 10-15 minutes, drink a hot tea made with 1 teas each of flax, fennel and fenugreek seeds (this will cool the warmth from the first drink). Do this daily for 2 weeks and then for 1 week every 6 months.

Food Chart

apples	Protects your heart	prevents constipation	Blocks diarrhea	Improves lung capacity	Cushions joints
apricots	Combats cancer	Controls blood pressure	Saves your eyesight	Shields against Alzheimer's	Slows aging process
artichokes	Aids digestion	Lowers cholesterol	Protects your heart	Stabilizes blood sugar	Guards against liver disease
avocados	Battles diabetes	Lowers cholesterol	Helps stops strokes	Controls blood pressure	Smoothes skin
bananas	Protects your heart	Quiets a cough	Strengthens bones	Controls blood pressure	Blocks diarrhea
beans	Prevents constipation	Helps hemorrhoids	Lowers cholesterol	Combats cancer	Stabilizes blood sugar
beets	Controls blood pressure	Combats cancer	Strengthens bones	Protects your heart	Aids weight loss
blueberries	Combats cancer	Protects your heart	Stabilizes blood sugar	Boosts memory	Prevents constipation
broccoli	Strengthens bones	Saves eyesight	Combats cancer	Protects your heart	Controls blood pressure
cabbage	Combats cancer	Prevents constipation	Promotes weight loss	Protects your heart	Helps hemorrhoids
cantaloupe	Saves eyesight	Controls blood pressure	Lowers cholesterol	Combats cancer	Supports immune system
carrots	Saves eyesight	Protects your heart	Prevents constipation	Combats cancer	Promotes weight loss
cauliflower	Protects against Prostate Cancer	Combats Breast Cancer	Strengthens bones	Banishes bruises	Guards against heart disease
cherries	Protects your heart	Combats Cancer	Ends insomnia	Slows aging process	Shields against Alzheimer's
chestnuts	Promotes weight loss	Protects your heart	Lowers cholesterol	Combats Cancer	Controls blood pressure
chili peppers	Aids digestion	Soothes sore throat	Clears sinuses	Combats Cancer	Boosts immune system
figs	Promotes weight loss	Helps stops strokes	Lowers cholesterol	Combats Cancer	Controls blood pressure
fish	Protects your heart	Boosts memory	Protects your heart	Combats Cancer	Supports immune system
flax	Aids digestion	Battles diabetes	Protects your heart	Improves mental health	Boosts immune system
garlic	Lowers cholesterol	Controls blood pressure	Combats cancer	kills bacteria	Fights fungus
grapefruit	Protects against heart attacks	Promotes Weight loss	Helps stops strokes	Combats Prostate Cancer	Lowers cholesterol
grapes	saves eyesight	Conquers kidney stones	Combats cancer	Enhances blood flow	Protects your heart
green tea	Combats cancer	Protects your heart	Helps stops strokes	Promotes Weight loss	Kills bacteria
honey	Heals wounds	Aids digestion	Guards against ulcers	Increases energy	Fights allergies
lemons	Combats cancer	Protects your heart	Controls blood pressure	Smoothes skin	Stops scurvy
limes	Combats cancer	Protects your heart	Controls blood pressure	Smoothes skin	Stops scurvy
mangoes	Combats cancer	Boosts memory	Regulates thyroid	aids digestion	Shields against Alzheimer's
mushrooms	Controls blood pressure	Lowers cholesterol	Kills bacteria	Combats cancer	Strengthens bones
oats	Lowers cholesterol	Combats cancer	Battles diabetes	prevents constipation	Smoothes skin
olive oil	Protects your heart	Promotes Weight loss	Combats cancer	Battles diabetes	Smoothes skin

References

1. Nutritive Values of Foods. Susan E. Gephardt and Ruth H. Matthews. U.S. Department of Agriculture, Human Nutrition Information Service, Home and Garden Bulletin No. 72, revised 1985, released 1986.
2. Composition of Foods: Nut and Seed Products...Raw, Processed, Prepared. Marie A. McCarthy and Ruth H. Matthews. U.S. Department of Agriculture Handbook No. 8-12, September 1984.
3. Nutritive Value of American Foods in Common Units. Catherine F. Adams. U.S. Department of Agriculture Handbook No. 456, 1975.
4. Composition of Foods: Fats and Oils...Raw, Processed, Prepared. James B. Reeves, III and John L. Weihrauch. U.S. Department of Agriculture Handbook No.8-4, 1979.
5. Composition of Foods: Poultry Products...Raw, Processed, Prepared. Linda P. Posati. U.S.Department of Agriculture Handbook No. 8-5, 1979.
6. Composition of Foods: Vegetables and Vegetable Products...Raw, Processed, Prepared. David B. Haytowitz and Ruth H. Matthews. U.S. Department of Agriculture Handbook No. 8-11, August 1984
7. Iron Content of Food. Jacob Exler. Home Economics Research Report No.45, Human Nutrition Information Service, U.S. Department of Agriculture, 1983
8. Posati, Linda P. and Martha L. Orr. Composition of Foods: Dairy & Egg Products...Raw,Processed, Prepared. U.S. Department of Agriculture Handbook 8-1.
9. Composition of Foods: Fruits and Fruit Juices...Raw, Processed, Prepared. Susan E. Gebhardt,Rena Cutrufelli and Ruth H. Matthews. U.S. Department of Agriculture Handbook No. 8-9,1982.
10. Recommended Dietary Allowances. National Academy of Sciences. National Research Council, 9th revised edition, 1980.
11. Nutritive Value of Foods. Catherine F. Adams and Martha Richardson. U.S. Department of Agriculture, Home and Garden Bulletin No. 72, revised 1981
12. Pantothenic Acid, Vitamin B6 and Vitamin B12 in Foods. Martha L. Orr. U.S. Department of Agriculture, Home Economics Research Report No.36, 1969.
13. Composition of Foods: Beverages...Raw, Processed, Prepared. Rena Cutrufelli and Ruth H. Matthews. U.S. Department of Agriculture Handbook No. 8-14, May 1986.
14. Nutrients in Foods. Gilbert A. Leveille, Mary Ellen Zabik and Karen J. Morgan. Cambridge,MA: The Nutrition Guild, 1983.
15. Composition of Foods...Raw, Processed, Prepared. Bernice K. Watt and Annabel L. Merrill.U.S. Department of Agriculture Handbook No. 8, revised 1963, reprinted 1975.
16. The Composition of Foods (McCance and Widdowson’s). A.A. Paul and D.A.T. Southgate. fourth revised and extended edition of Medical Research Council’s Special Report No. 297, Her Majesty’s Stationery Office, Elsevier/North-Holland Biomedical Press
17. Comparisons of Methods for Calculating Retentions of Nutrients in Cooked Foods. Elizabeth W. Murphy, Patricia E. Criner and Bruce C. Gray. Journal Agric. Food Chemistry 23:1153,1975.
18. Vitamin B6 Components in Fresh and Dried Vegetables. Marilyn M. Polansky. Journal of American Dietetic Association 54:118, 1969.
19. Nutrients in Cooked and Frozen Vegetables. L.J. Teply, Ph.D. and P.H. Derse. Journal of American Dietetic Association, 1958.
20. Thiamin, Riboflavin, and Vitamin B6 Contents of Selected Foods as Served. Michael H. Dong, MPH, MPA, Evelyn L.McGown, PhD, Bruce W. Schwenneker and Howerde W. Sauberlich, PhD. Journal of American Dietetic Association 76:156, 1980.
21. Vitamin B6 in Reheated, Held, and Freshly Cooked Turkey Breast. Pamela P. Engler and Jane A. Bowers, PhD. Journal of American Dietetic Association 67:42, 1975.
22. Vitamin B6 Components in Fruits and Nuts; Marilyn M. Polansky and Elizabeth W. Murphy; Journal of Am. Dietetic Assoc. 48:109, 1966
23. Lesser Known Vitamins in Foods; Mervyn G. Hardinge, MD, DR, PH, PhD and Hulda Crooks; Journal of Am. Dietetic Assoc. 38:230, 1961
24. Nutritional Value of Dehydrated Foods; Miriam H. Thomas and Doris H. Calloway, PhD; Journal of Am. Dietetic Assoc. 39:105, 1961
25. Pantothenic Acid Content of 75 Processed and Cooked Foods; Joan H. Walsh, PhD, RD,Bonita W. Wyse, PhD, RD and R. Gaurth Hansen, PhD; Journal of Am. Dietetic Assoc. 78:130, 1981.
26. Pantothenic Acid and Vitamin B6 in Beef; Bernadine H. Meyer, PhD, Mary A. Mysinger and Lois A. Wodarski; Journal of Am. Dietetic Assoc.; v. 54:122, 1969.
27. Retention of the B Vitamins in Beef and Lamb After Stewing. III. Pantothenic Acid; Sylvia Cover, Esther M. Dilsaver and Rene M. Hays; Journal of Am. Dietetic Assoc; v.23:696, 1947.
28. Vitamin B12...Microbiological Assay Methods and Distribution in Selected Foods; Harold Lichtenstein, Aram Beloian and Elizabeth W. Murphy; U.S. Department of Agriculture Home Economics Research Report No. 13, 1961
29. Vitamin B12, E, and D Content of Raw and Cooked Beef; M.R. Bennink and K. Ono; Journal of Food Science; v.47:1786, 1982
30. The Vitamin B12 Content of Meals and Items of Diet; J.F. Adams, Fiona McEwan and Alison Wilson; British Journal of Nutrition; v.29:65, 1973.
31. Mineral Elements in Fresh Vegetables from Different Geographic Areas; Homer Hopkins and Jacob Eisen; Agriculture and Food Chemistry; v.7,n.9:643, 1959.
32. Essential Mineral Elements in Peanuts and Peanut Butter; Leila C.A. Galvao, Anthony Lopez and Harriet L. Williams; Journal of Food Science; v.41:1305, 1976.
33. Copper Content of Foods; Jean T. Pennington PhD and Doris H. Calloway, PhD, RD; Journal of American Dietetic Association; v.63:143, 1973.
34. Copper Content of Some Low-Copper Foods; Liesbeth Hook and Ira K. Brandt, MD; Journal of Am. Dietetic Assoc.; 202, 1966.
35. Zinc and Copper Content of Foods Used in Vegetarian Diets; Jeanne H. Freeland-Graves PhD, RD;M. Lavone Ebangit and Pamela W. Bodzy; Journal of Am. Dietetic Association; v.77:648, 1980.
36. Zinc Content of Selected Foods; Kathryn A. Haeflein and Arlette I. Rasmussen, PhD, RD; Journal; of Am. Dietetic Assoc.; v.30:610, 1977.
37. Zinc Content of Selected Foods; Jeanne H. Freeland, PhD and Robert J. Cousins, PhD; Journal of Am. Dietetic Assoc.; v.68:526, 1976.
38. Provisional Tables on the Zinc Content of Foods; Elizabeth W. Murphy, Barbara W. Willis and Bernice K. Watt, PhD, RD; Journal of Am. Dietetic Assoc.; v.66:345, 1975.
39. The Zinc and Copper Content of Seeds and Nuts; Kenneth G.D. Allen, Leslie M. Klevay and Hugh L. Springer; Nutrition Reports International; v.12:75, 1975.
40. Magnesium Content of Selected Foods; J.L. Greger, S. Marhefka and A.H. Geissler; Journal of Food Science;v.43:1610, 1978.
41. Magnesium Content of Accessory Foods; Gweneth Y. Nelson and Mary R. Gram, PhD; Journal of Am. Dietetic Assoc.; v.38:437, 1960.
42. Yields, Proximate Composition and Mineral Content of Finfish and Shellfish; Jane E. Anthony, Pauline N. Hadgis, Rhonda S. Milam Gudrun A. Herzfeld, L. Janette Taper and S.J. Richey; Journal of Food Science; v.48:313, 1983.
43. Mineral and Proximate Composition of Pacific Coast Fish; Dennis T. Gordon and G. Louis Roberts; Journal of Agric. Food Chemistry; v.25:1262, 1977.
44. Nutritive Value of Fish. I. Nicotinic Acid, Riboflavin, Vitamin B12, and Amino Acids of Various Salt-Water Species; A.E. Teeri, M.E. Loughlin and D. Josselyn; Food Research; v.22:145, 1957.
45. The Content of Nine Mineral Elements in Raw and Cooked Mature Dry Legumes; Christine R. Meiners, Nellie L. Derise, Herbert C. Lau, Michael G. Crews, S.J. Richey and Elizabeth W. Murphy; Journal of Agric. Food Chemistry; v.24:1126, 1976.
46. Ascorbic Acid Retention in Frozen Corn; Irene R. Payne, PhD; Journal of Am. Dietetic Assoc.; v.51:344, 1967.
47. Selenium Content of Foods; V.C. Morris and O.A. Levander; Journal of Nutrition; v.100:1383, 1930.
48. Selenium Content of Canadian Foods; D. Arthur; Canadian Inst. Food Science Technology Journal; v.5:165, 1972.
49. Selenium and Chromium in Human Nutrition; Orville A. Levander, PhD; Journal of Am. Dietetic Assoc.; v.66:338, 1975.
50. Selenium Content of Selected Foods; Helen W. Lane, PhD, RD; Barbara J. Taylor; Elizabeth Stool, RD; Diane Servance and Doris C. Warren PhD; Journal of Am. Dietetic Assoc.; v.82:24, 1983.
51. Nutritive Value of Canned Foods...Vitamin B6, Folic Acid, Beta-Carotene, Ascorbic Acid, Thiamine, Riboflavin, and Niacin Content and Proximate Composition; L.J. Teply, P.H. Derse and C.H. Krieger; Agriculture and Food Chemistry; v.1:1204, 1953.
52. Effect of Processing on Provitamin A in Vegetables; J.P. Sweeney and A.C. Marsh; Journal of Am. Dietetic Assoc.; v.59:238, 1971
53. Folic Acid Content of Foods...Micro- biological Assay by Standardized Methods and Compilation of Data from Literature; Edward W. Toepfer, Elizabeth G. Zook and Martha L. Orr; U.S. Department of Agriculture Handbook No. 29, 1951.
54. Cheese Products: Protein, Moisture, Fat, and Acceptance; Pamela J. Nystrom, Joyce G. Ostrander, PhD and Charlene S. Martinsen, RD; Journal of Am. Dietetic Assoc.; v.65:30, 1974
55. Folate Distribution in Fruit Juices; Faye M. Dong and Susan M. Oace, PhD, RD, Journal of Am. Dietetic Assoc.; v.62:162, 1973.
56. Vitamin E Content of Foods; P.J. McLaughlin, PhD and John L. Weihrauch; Journal of Am. Dietetic Assoc.; v.75:647, 1979.
57. Vitamin E Adequacy of Vegetable Oils; J.G. Bieri, PhD and R. Poukka Evars, DVM; Journal of Am. Dietetic Assoc.; v.66:134, 1975.
58. Tocopherol Contents of Vegetables and Fruits; V.H. Booth and M.P. Bradford; British Journal of Nutrition; v.17:575, 1963.
59. Tocopherols in Foods and Fats; Hal T. Slover; Lipids; v.6,n.5:291, 1971.
60. Alpha-Tocopherol Content of Foods; R.H. Bunnel, PhD; J. Keating, BS, A. Quaresimo, BS; and G.K. Parman, BS; The American Journal of Clinical Nutrition; v.17:1, 1965.
61. Nutrients in Fresh Peeled Oranges and Grapefruit from California and Arizona; James A. Staroscik, Felipe U. Gregorio, Jr. and Samuel K. Reeder, PhD; Journal of Am. Dietetic Assoc.; v.77:567, 1980.
62. Nutrients in California Lemons and Oranges; John J. Birdsall, Philip H. Derse and Lester J. Teply; Journal of Am. Dietetic Assoc.; v.38:555, 1961.
63. Mineral Composition of Fruits: Nitrogen, Calcium, Magnesium, Phosphorus, Potassium, Aluminum, Boron, Copper, Iron, Manganese, and Sodium; Elizabeth G. Zook and Joanna Lehmann; Journal of Am. Dietetic Assoc.; v.52:225, 1968.
64. Mineral Composition of Fruits: Edible Yield, Total Solids, and Ash of 30 Fresh Fruits; Elizabeth G. Zook; Journal of Am. Dietetic Assoc.; v.52:218, 1968.
65. Mineral Content of Dairy Products: II. Cheeses; N.P. Wong, PhD;, D.E. LaCroix and John A. Alford, PhD; Journal of Am. Dietetic Assoc.; v.72:608, 1978.
66. Major Mineral Elements in Dairy Products; Ruth M. Feeley, Patricia E. Criner, Elizabeth W. Murphy and Edward W. Toepfer, PhD; Journal of Am. Dietetic Assoc.; v.61:505, 1972.
67. Mineral Contents of Selected Pre-Prepared Foods Sampled in a Hospital Food Service Line; Cecilia Leung, PhD., RD, Helen H. Koehler and Margaret M. Hard; Journal of Am. Dietetic Assoc.; v.80:530, 1982.
68. Nutrients in Raw vs. Cooked Globe Artichokes; Bessie B. Cook, PhD and Saroja Sundaram; Journal of Am. Dietetic Assoc.; v.42:231, 1963.
69. Simultaneous Determination of Thiamin and Riboflavin in Selected Foods by High-
70. Performance Liquid Chromatography; J.K. Fellman, W.E. Artz, P.D. Tassinari, C.L. Cole and J. Augustin; Journal of Food Science; v.47:2048, 1982.
71. Computerized Nutrient Data Bases: I. Comparison of Nutrient Analysis Systems; Loretta W. Hoover, PhD, RD; Journal of Am. Dietetic Assoc.; v.82:501, 1983.
72. Computerized Nutrient Data Bases; II. Development of Model for Appraisal of Nutrient Data
73. Base System Capabilities; Loretta W. Hoover, PhD, RD and Betty P. Perloff; Journal of Am.
74. Dietetic Assoc.; v.85:506, 1982
75. The Complete Book of Vitamins; staff of Prevention Magazine; compiled and prepared by C. Gerras; Rodale Press, Emmaeus, PA, 1977.
76. Comparisons of Methods for Calculating Retentions of Nutrients in Cooked Foods; E.W. Murphy, P.E. Criner, B.C. Gray; Journal of Agric. and Food Chemistry, v.2 3:6, p.1153, 1975.
77. You Are What You Eat; V.H. Lindlahr; Lancer Books, Inc., NY, 1972.
78. Understanding Nutrition; E.N. Whitney and W.M.N. Hamilton; West Publishing Company, NY, second edition 1981, third edition 1987, and fifth edition 1990.
79. Fundamentals of Normal Nutrition; C.H. Robinson; MacMillan Publishing Co., NY, third edition, 1977.
80. Normal and Therapeutic Nutrition; C.H. Robinson and M.R. Lawler; MacMillan Publishing Co., NY, fifteenth edition, 1977.
81. Introduction to Nutrition; H. Fleck; MacMillan Publishing Co. Inc., NY, third edition, 1976.
82. The World Encyclopedia of Food; L.P. Coyle, Facts on File, Inc., NY, 1982.
83. Information Resources for Food and Human Nutrition; R.C. Frank; Journal of Am. Dietetic Associations; v.80-344, 1983.
84. The Sodium and Potassium Content of Selected Vegetables; Anne C. Marsh and Percilla C. Koons, RD; Journal of Am. Dietetic Assoc.; v.83:24, 1983.
85. Nutrient Composition of Stone Fruit (Prunus spp.) Cultivars: Apricots, Cherry, Nectarine, Peach and Plum; Ron B.H. Wills, Frances M. Scriven and Heather Greenfield; Journal of the Science of Food and Agriculture; v.34:1383, 1983.
86. Sprouting of Seeds and Nutrient Composition of Seed and Sprouts; J.R. Fordham, C.E. Wells and L.H. Chen; Journal of Food Science; v.30:552, 1975.
87. Nutrients in Seeds and Sprouts of Alfalfa, Lentils, Mung Beans and Soybeans; Anne M. Kylen and Rolland M. McCready; Journal of Food Science; v.30:1008, 1975.
88. Tocopherols in Nuts; G. Lambertsen, H. Myklestad and O.R. Braekkan; Journal of the Science of Food and Agriculture; v.13:617, 1962.
89. EMeasurement of Glycosylated Vitamin B6 in Foods; Hossein Kabir, James Leklem and
90. Lorraine T. Miller; Journal of Food Science v.48:14-42, 1983.
91. Food Manufacture and Nutrition; Arnold E. Bender; Nutrition Reviews Supplement; January 1982.
92. Pantothenic Acid in Foods; E.G. Zook, M.J. MacArthur, and E.W. Toepfer; U.S. Department of Agriculture Handbook No. 97, 1956.
93. The Distribution of Folic Acid Active Compounds in Individual Foods; Rafael Santini, PhD,;Carol Brewster, BS and C.E. Butterworth, Jr., MD; The American Journal of Clinical Nutrition; v.14:205, 1964.
94. Beneficial Physiologic Action of Beans; E.W. Hellendoorn, PhD; Journal of Am. Dietetic
95. Assoc.; v.69:248, 1976.
96. Unpublished Data on Vitamin B-6, Selenium, and Other Nutrients in Foods, 1983; Professor James E. Leklem, Dept. of Foods and Nutrition, Oregon State University.
97. Selenium in Crops in the United States in Relation to Selenium-Responsive Diseases in.Animals; J. Kubota, W.H. Allaway, D.L. Carter, E.E. Cary and V.A. Lazar; Journal of Agric. and Food Chemistry; v.15:448,1967.
98. The B Vitamin Content of Grapes, Musts, and Wines; Alice P. Hall, Lisa Brinner, Maynard A. Amerine, and Agnes Fay Morgan; Food Research; v.21:362, 1956.
99. The Value of Dairy Products in Nutrition; Royal A. Sullivan, Evelyn Bloom and Joan Jarmol; Journal of Nutrition; 1942-45.
100. Nutrients in Vegetarian Foods; Delores D. Truesdell, Eleanor N. Whitney, PhD, RD and Phyllis B. Acosta, Dr. P.J., RD; Journal of Am. Dietetic Assoc.; v.84:28, 1984.
101. Gamma Tocopherols: Metabolism, Biological Activity and Significance in Human Vitamin E Nutrition; John C. Bieri, PhD, and R. Poukka Evarts, DVM; The American Journal of Clinical Nutrition; v.27:980, 1974.
102. Vitamin A Activity of Selected Fruits; C.D. Johnson; R.R. Eitenmiller, PhD; D.A. Lillard, PhD and M. Rao, PhD; Journal of The American Dietetic Associaton; vol.85:1627, December 1985.
103. Yields and Nutrient Content of Selected Fresh Fruits; L. Janette Taper, PhD; Deborah A. McNeill, PhD, and S.J. Ritchey, PhD; Journal of The American Dietetic Association; vol.85:718, June 1985.
104. Mineral Analyses of Vegetarian, Health, and Conventional Foods: Magnesium, Zinc, Copper, and Manganese Content; Deborah A. McNeill, PhD; Perveen S. Ali, MS, and Young S. Song, MS; Journal of The American Dietetic Association; vol. 85:569, May 1985.
105. Selenium and Vitamins A, E, and C: Nutrients with Cancer Prevention Properties; Ronald Ross Watson, PhD and Tina K. Leonard; Journal of The American Dietetic Association; vol.86:505, April 1986.
106. New Carrot Excels in Carotene and Flavor; The Journal of The American Dietetic
107. Association; From Agricultural Research, 32 (May): 12, 1984.
108. Composition of Red Delicious Apples; C.D. Johnson, R. R. Eitenmiller, J. B. Jones, Jr., V. N. M. Rao, and S.E. Gebhardt; Journal of Food Science; vol.49:952, 1984.
109. Nutrient Composition of Cantaloupe and Honeydew Melons; R. R. Eitenmiller, C. D. Johnson, W. D. Bryan, D. B. Warren, and S. E. Gebhardt; Journal of Food Science; vol.50:136, 1985.
110. Mineral and Vitamin Content of Goat’s Milk; Wajih N. Sawaya, Ph.D., Jehangir K. Khalil, Ph.D., and Abdullah F. Al-Shalhat, B.Sc.; The Journal of The American Dietetic Association; vol.84:433, April 1984.
111. Vitamin E Composition of Some Seed Oils as Determined by High-Performance Liquid Chromatography with Fluorometric Detection; A. J. Speek, J. Schriver, and W.H P. Schreurs; Journal of Food Science; vol.50:121, 1985.
112. Nutritional Composition of Bagels Commercially Produced in the United States; C.S. Ranhotra, J.A. Geiroth, and F.A. Novak; Cereal Foods World; vol.30:209, March 1985.
113. B Vitamins in Selected Variety Breads Commercially Produced in Major US Cities; Gur.Ranhotra, Janette Gelroth, Frances Novak, and Ruth Matthews; Journal of Food Science; vol.50:1174, 1985.
114. Food Composition Table from Unpublished Manuscript; Christine Heller, Nutritionist; Arctic Health Research Center; US Dept. HEW, Anchorage, Alaska.
115. Mineral Content of Foods and Total Diets: The Selected Minerals in Foods Survey, 1982 to 1984; Jean A.T. Pennington, Ph.D., R.D.; Barbara E. Young; Dennis B. Wilson; Roger D. Johnson; and John E. Vanderveen, Ph.D; Journal of the American Dietetic Association; vol.86:878; July 1986.
116. Vitamin E in Foods from High and Low Linoleic Acid Diets; J. Lehmann, M.S., and J.T. Judd, Ph.D.; Journal of the American Dietetic Association; vol.86:1208; September 1986.
117. Vitamin E intakes and sources in the United States by S.P. Murphy, A.M. Subar and G. Block. American Journal of Clinical Nutrition 52:361-367, 1990.
118. HPLC Determination of Carotenoids in Fruits and Vegetables in the United States; Janice L. Bureau and Rodney J. Bushway; Journal of Food Science; vol.51:128; 1986.
119. Provisional Table on Percent Retention of Nutrients in Food Preparation; USDA, Human Nutrition Information Service, revised April 1984.
120. Composition of Foods: Snacks and Sweets... Raw, Processed, Prepared; by Rena Cutrufelli and Pamela Pehrsson. Nutrient Data Research Branch, Nutrition Monitoring Division, USDA Human Nutrition Information Service, Agriculture Handbook No. 8-19; 1991.
121. Report of Vitamin Analysis for Broccoli and Cauliflower, by Dr. Joseph Monteclavo. San Luis Obispo, CA: California Polytechnic State University.
122. Provisional Table on Percent Retention of Nutrients in Food Preparation. US Department of Agriculture Nutrient Data Research Group, Beltsville, MD, 1992.
123. Vitamin B-12: plant sources, requirements, and assay by V. Herbert, MD, JD. American Journal of Clinical Nutrition, 48:852-858, 1988.
124. Iron, zinc, copper, manganese, selenium, and iodine in foods from the United States Total Diet Study by J.A.T. Pennington and B. Young. Journal of Food Composition and Analysis 3:166-184, 1990.
125. Effects of process stage and storage on retention of beta-carotene in tomato juice by J.M. Dietz and W.A. Gould. Journal of Food Science 51(3):847-848, 1986.
126. Determination of beta-carotene and other hydrocarbon carotenoids in red grapefruit cultivars by R.L. Rouseff, G.D. Sadler, T.J. Putnam and J.E. Davis. Journal of Agricultural Food Chemistry 30:47-51, 1992.
127. Chromium in nutrition and disease by G. Saner. Current Topics in Nutrition and Disease Series, Vol. 2. Alan R. Liss, Inc., 1980.
128. Journal of Food Composition and Analysis Vol. 3, No. 4, December 1992
129. Sternberg EM. The Balance Within: The Science Connecting Health and Emotions.New York: WH Freeman and Company, 2000.
130. Thompson WG. Placebos: A review of the placebo response. Am J Gastroenterol 2000;95( 7):1637-43.
131. Nowotny A. In: Nowotny, editor. Beneficial effects of endotoxins. New York, Plenum Press, 1993;1-55.
132. Hammar JA. The new views as to the morphology of the thymus gland and their bearing on the problem of the function of the thymus. Endocrinology 1921;5:543-73, 731-60.
133. Smith PE. Effects of hypophysectomy upon the involution of the thymus in the rat. Anat Rec 1930; 47:119-29.
134. Selye H. A syndrome produced by diverse nocuous agents. Nature (Lond) 1936;138:32.
135. Selye H. Thymus and adrenals in the response of the organism to injuries and intoxication. Brit J Exp Path 1936; 17:234-248.
136. Selye H. Morphological changes in the fowl following chronic overdosage with various steroids. J Morph 1943;73:301-421.
137. Selye H. The general adaptation syndrome and the diseases of adaptation. J Clin Endocrinology 1946;6: 117-230.
138. Selye H. Effect of ACTH and cortisone upon an "anaphylactoid reaction". Can Med Assoc J 1949;61: 553-556.
139. Selye H. Stress and disease. Science 1955;122:625-31.
140. Selye H. The Mast Cells. Washington: Butterworth, 1965.
141. Filipp G, Szentivanyi A, Mess B. Anaphylaxis and nervous system. Acta Med Hung 1952;2:163-73.
142. Szentivanyi A, Filipp G. Anaphylaxis and the nervous system. Part II. Ann Allergy 1958;16:143-151.
143. Filipp G, Szentivanyi A. Anaphylaxis and the nervous system. Part III. Allergy 1958;16: 306-11.
144. Szentivanyi A, Szekely J. Effect of injury to, and electrical stimulation of, hypothalamic areas on anaphylactic and histamine shock of the guinea pig. A preliminary report. Ann
145. Allergy 1956;14:259-261.
146. Townley RG, Trapani IL, Szentivanyi A. Sensitization to anaphylaxis and to some of its pharmacological mediators by blockade of the beta adrenergic receptors. J Allergy 1967;39( 3):177-79.
147. Szentivanyi A. The beta adrenergic theory of the atopic abnormality in bronchial asthma. J Allergy 1968;42:203-32.
148. Szentivanyi A, Szentivanyi J, Wagner H. Measurement of numbers of adrenoceptors in lymphocytes and lung tissue of patients with reversible obstructive airways disease.
149. Clin Pharmacol Ther 1980;27:193-206.
150. Szentivanyi A. The conformational flexibility of adrenoceptors and the constitutional basis of atopy. Triangle 1979;18( 4):109-15.
151. Szentivanyi A, Heim O, Schultze P. Changes in adrenoceptor densities in membranes of lung tissue and lymphocytes from patients with atopic disease. Ann NY Acad Sci 1979;332:295-298.
152. Szentivanyi A. La flexibilite de conformation des adrenocepteurs et la base constitutionelle du terrain allergique. Rev Franc Allergol 1979;19:205-214.
153. Szentivanyi A, Fitzpatrick DF. The altered reactivity of the effector cells to antigenic and pharmacological influences and its relation to cyclic nucleotides. II. Effector reactivities in the efferent loop of the immune response. In: Filipp G, editor. Pathomechanismmus und Pathogenese Allergischer Reaktionen. Werk-Verlag Dr. Edmund Banachewski,
154. Grafelfing bei Munchen 1980;511-580.
155. Szentivanyi A, Polson JB, Krzanowski JJ. The altered reactivity of the effector cells to antigenic and pharmacological influences and its relation to cyclic nucleotides. I. Effector reactivities in the efferent loop of the immune response. In: Filipp G, editor. Pathomechanismus und Pathogenese Allergischer Reaktionen. Werk-Verlag, Dr. Edmund Banachewski, Grafelfing bei Munchen 1980; 460-510.
156. Szentivanyi A, Krzanowski JJ, Polson JB, Anderson WH. Evolution of research strategy in the experimental analysis of the beta adrenergic approach to the constitutional basis of atopy. In: Oehling A, Mathov E, Glazer I, Arbesman C, editors. Advances in Allergology and Clinical Immunology. Oxford, Pergamon Press, 1980;301-308.
157. Szentivanyi A. Effect of bacterial products and adrenergic blocking agents on allergic reactions. In: Samter M, Talmage DW, Rose B, Sherman WB, Vaughan JH, editors.
158. Textbook of Immunological Diseases. Boston, MA: Little, Brown and Co. 1971;356-374.
159. Szentivanyi A, Krzanowski JJ, Polson JB. The autonomic nervous system: Structure, function, and altered effector responses. In: Middleton E, Reed CE, Ellis EF, editors.
160. Allergy: Principles and Practice. St. Louis, MO, The CV Mosby Co, 1978;256-300.
161. Szentivanyi A, Williams JF. The constitutional basis of atopic disease. In: Bierman CW, Pearlman DS, editors. Allergic Diseases of Infancy, Childhood, and Adolescence. Philadelphia, PA, WB Saunders Co1980;173-210.
162. Szentivanyi A. Adrenergic and cholinergic receptor studies in human lung and lymphocytic membranes and their relation to bronchial hyperreactivity in asthma. In: Patient Care Publications. Darien, CT, 1982;175-92.
163. Hackney JF, Szentivanyi A. The specificity of glucocorticoids in the relaxation of respiratory smooth muscle in vitro. J Allergy Clin Immunol 1975;55:123. (abstract).
164. Hackney JF, Szentivanyi A. The unique action of glucocorticoid succinates on respiratory smooth muscle in vitro. The Pharmacologist 1975;17:271. (abstract).
165. Lowitt S, Szentivanyi A, Williams JF. Endotoxin inhibition of dexamethasone induction of tryptophan oxygenase in suspension culture of isolated rat parenchymal cells. II.
166. Effect of in vivo pretreatment of rats with endotoxin. Biochem Pharmacol 1982;31:3303-3306.
167. Szentivanyi A, Szentivanyi J. Mechanisms of action of corticosteroids. In: Proceedings of the International Symposium on Allergy and Immunology. Lima, Peru, 1985; 531-534.
168. Korneva EA, Khai LM. Effect of destruction of hypothalamic areas on immunogenesis. Fed Proc 1964;23: T88.
169. Jancso N. Role of the nerve terminals in the mechanism of inflammatory reactions. Bull. Millard Fillmore Hosp (Buffalo NY) 1960;7-53.
170. Jancso N. Desensitization with capsaicin and related acylamides as tool for studying the function of pain receptors. In: RKS Lim, editor. Pharmacology of Pain. Oxford, Pergamon Press, 1968.
171. Dougherty TF. Effect of hormones on lymphatic tissue. Physiol Rev 1952;32:379-307.
172. Nagy E, Berczi I. Immunodeficiency in hypophysectomized rats. Acta Endocrinology 1978;89:530-537.
173. Berczi I, Nagy E, Kovacs K, Horvath E. Regulation of humoral immunity in rats by pituitary hormones. Acta Endocrinology 1981;98:506-513.
174. Nagy E, Berczi I, Friesen HG. Regulation of immunity in rats by lactogenic and growth hormones. Acta Endocrinology 1983;102:351-357.
175. Nagy E, Berczi I, Wren GE, Asa SL, Kovacs K. Immunomodulation by bromocriptine. Immunopharmacology 1983;6:231-243.
176. Berczi I (author/ editor). Pituitary Function and Immunity (with 12 contributing authors). Monograph published by: CRC Press, Inc., Boca Raton, FL, 1986.
177. Wannemacher RW Jr, Pekarek RS, Thompson WL, et al. A protein from polymorphonuclear leukocytes (LEM) which affects the rate of hepatic amino acid transport and synthesis of acute-phase globulins. Endocrinology 1975;96: 651-661.
178. Besedovsky HO, del Rey A, Sorkin E. lymphokine-containing supernatants from Con A-stimulated cells increase corticosterone blood levels. J Immunol 1981; 126:385-7.
179. Berkenbosch F, van Oers J, del Rey A, Tilders F, Besedovsky H. Corticotropin-releasing factor-producing neurons in the rat activated by interleukin-1. Science 1987; 238:524-526.
180. Sapolsky R, Rivier C, Yamamoto G, Plotsky P, Vale W. Interleukin-1 stimulates the secretion of hypothalamic corticotropin-releasing factor. Science 1987;238:522-524.
181. Nakamura H, Motoyoshi S, Kadokawa T. Anti-inflammatory action of interleukin 1 through the pituitary-adrenal axis in rats. Eur J Pharmacol 1988;141:67-73.
182. Uehara A, Gottschall PE, Dahl RR, Arimura A. Interleukin-1 stimulates ACTH release byan indirect action which requires endogenous corticotropin releasing factor. Endocrinology 1987;121:1580-1582.
183. Bernton EW, Beach JE, Holaday JW, Smallridge RC, Fein HG. Release of multiple hormones by a direct action of interleukin-1 on pituitary cells. Science 1987;238:519-521.
184. McCann SM, Karanth S, Kamat A, Les Dees W, Lyson K, Gimeno M, Rettori V.Induction by cytokines of the pattern of pituitary hormone secretion in infection. Neuroimmunomodulation 1994;1:13.
185. Pletsityi DF, Averi'anova LL. The influence of vagotomy on the development of experimental endocarditis. Dokl Akad Nauk SSSR 1966; Mar 1;167( 1):238-30. Russian
186. Williams JM, Petersen RG, Shea PA, Schemdtje JF, Bauer DC, Felten DL. Sympathetic innervation of murine thymus and spleen: evidence for a functional link between the nervous and immune systems. Brain Res Bull 1981; Jan; 6( 1):83-94.
187. Nance DM. Innervation of the spleen in the rat: evidence for absence of afferent innervation. Burns J Brain Behav Immun 1989; Dec; 3( 4):281-90.
188. Fleshner M, Goehler LE, Hermann J, Relton JK, Maier SF, Watkins LR. Interleukin-1beta induced corticosterone elevation and hypothalamic NE depletion is vagally mediated. Brain Res Bull 1995;37( 6):605-10.
189. Metal'nikov S, Chorine V. Roles des refl exes conditionels dans l'immunite. Ann Inst Pasteur 1926;30:893-900.
190. Smith GH, Salinger R. Hypersensitivity and the conditioned refl ex. Yale J Biol Med 1933;5:387-302.
191. Ader R. Letter: Behaviorially conditioned immunosuppression. Psychosom Med 1974;36( 2): 183-184.
192. MacQueen G, Marshall J, Perdue M, Siegel S, Bienenstock J. Pavlovian conditioning of rat mucosal mast cells to secrete rat mast cell protease II. Science 1989;243:83-85.
193. Gorczynski RM, Macrae S, Kennedy M. Conditioned immune response associated with allogeneic skin grafts in mice. J Immunol 1982;129:304-9.
194. Johnson HM, Smith EM, Torres BA, Blalock JE. Regulation of the in vitro antibody response by neuroendocrine hormones. Proc Nat Acad Sci USA 1982;Sci 79:4171-4.
195. Montgomery DW, Zukoski CF, Shah GN, Buckley AR, Pacholczyk T, Russell DH. Concanavalin A-stimulated murine splenocytes produce a factor with prolactin-like bioactivity and immunoreactivity. Biochem Biophys Res Commun 1987; Jun 15;145( 2):692-8.
196. DiMattia, Gellersen B, Duckworth ML, Friesen HG. Human prolactin gene expression. The use of an alternative noncoding exon in decidua and the IM-9-P3 lymphoblast cell line. J Biol Chem 1990; Sept 25; 265( 27): 16412-21.
197. Salamonsen LA, Woolley DE. Menstruation: induction by matrix metalloproteinases and inflammatory cells. J Reprod Immunol 1999; Sept;44( 1-2):1-27.
198. Kim HG, Kassis J, Souto JC, Turner T, Wells A. EGF receptor signaling in prostate morphogenesis and tumorigenesis. Histol Histopathol 1999;Oct;14( 4):1175-82.
199. Bodey B, Bodey B Jr, Siegel SE, Kaiser HE. Molecular biological ontogenesis of the thymic reticulo-epithelial cell network during the organization of the cellular microenvironment. In Vivo. 1999; May-Jun;13( 3):267-94.
200. Bianco P, Riminucci M, Kuznetsov S, Robey PG. Multipotential cells in the bone marrow stroma: regulation in the context of organ physiology. Crit Rev Eukaryot Gene Expr 1999;9( 2):159-73.
201. Robinson GW, Karpf AB, Kratochwil K. Regulation of mammary gland development by tissue interaction. J Mammary Gland Biol Neoplasia 1999; Jan; 4( 1):9-19.
202. Maeurer MJ, Lotze MT. Interleukin-7 (IL-7) knockout mice. Implications for lymphopoiesis and organ-specific immunity. Int Rev Immunol 1998;16( 3-4):309-22.
203. Fidler IJ. Angiogenesis and cancer metastasis. Cancer J Sci Am 2000; Apr; 6 Suppl 2:S134-41.
204. King A. Uterine leukocytes and decidualization. Hum Reprod Update 2000; Jan-Feb;6( 1):28-36.
205. Wagner JG, Roth RA. Neutrophil migration mechanisms, with an emphasis on the pulmonary vasculature. Pharmacol Rev 2000; Sept;52( 3):349-74.
206. Pirtskhalaishvili G, Nelson JB. Endothelium-derived factors as paracrine mediators of prostate cancer progression. Prostate 2000; Jun 15;44( 1):77-87.
207. Tanaka Y. Integrin activation by chemokines: relevance to infl ammatory adhesion cascade during T cell migration. Histol Histopathol 2000; Oct;15( 4):1169-76.
208. Alford D, Taylor-Papadimitriou J. Cell adhesion molecules in the normal and cancerous mammary gland. J Mammary Gland Biol Neoplasia 1996; Apr;1( 2):207-18.
209. Kimber SJ, Spanswick C. Blastocyst implantation: the adhesion cascade. Semin Cell Dev Biol 2000; Apr;11( 2): 77-92.
210. Shiosaka S, Yoshida S. Synaptic microenvironments -- structural plasticity, adhesion molecules, proteases and their inhibitors. Neurosci Res 2000; Jun;37( 2):85-9.
211. Renard V, Cambiaggi A, Vely F, Blery M, Olcese L, Olivero S, Bouchet M, Vivier E. Transduction of cytotoxic signals in natural killer cells: a general model of fine tuning between activatory and inhibitory pathways in lymphocytes. Transplant Rev 1997;155:205-221.
212. Daëron M. Fc receptor biology. Annu. Rev Immunol 1997; 15:203-34.
213. Isakov N. Immunoreceptor thyrosine-based activation motif (ITAM), a unique module linking antigen and Fc receptors to their signaling cascades. J Leukoc Biol 1997; 61:6-16.
214. Venters HD, Tang Q, Liu Q, VanHoy RW, Dantzer R, Kelley KW. A new mechanism of neurodegeneration: a proinflammatory cytokine inhibits receptor signaling by a survival peptide. Proc Natl Acad Sci USA 1999; Aug 17; 96( 17):9879-84.
215. Yee D, Lee AV. Crosstalk between the insulin-like growth factors and estrogens in breast cancer. J Mammary Gland Biol Neoplasia 2000; Jan; 5( 1):107-15.
216. Kawashima K, Fujii T. Extraneuronal cholinergic system in lymphocytes. Pharmacol Ther 2000; Apr; 86( 1):29-48.
217. Ptasznik A, Gewirtz AM. Crosstalk between G protein - coupled receptors and tyrosine kinase signaling: Src take centre stage. Arch Immunol Ther Exp (Warsz) 2000;48( 1):27-30.
218. Bornfeldt KE, Krebs EG. Crosstalk between protein kinase A and growth factor receptor signaling pathways in arterial smooth muscle. Cell Signal 1999; Jul; 11( 7):465-77.
219. Folli F, Saad MJ, Velloso L, Hansen H, Carandente O, Feener EP, Kahn CR. Crosstalk between insulin and angiotensin II signalling systems. Exp Clin Endocrinol Diabetes 1999; 107( 2):133-9.
220. Paul WE. The immune system: An introduction. In: Paul WE, editor. Fundamental Immunology, 4th edition. Lippincott-Raven, 1999;1-35.
221. Clevenger CV, Freier DO, Kline JB. Prolactin receptor signal transduction in cells of the immune system. J Endocrinol 1998;157:187-197.
222. Chang L, Crowston JG, Cordeiro MF, Akbar AN, Khaw PT. The role of the immune system in conjunctival wound healing after glaucoma surgery. Surv Ophthalmol 2000; Jul-Aug;45( 1):49-68.
223. Schwartz M, Cohen IR. Autoimmunity can benefit self-maintenance. Immunol Today 2000; Jun; 21( 6):265-8.
224. Neumann H. The immunological microenvironment in the CNS: implications on neuronal cell death and survival. J Neural Transm Suppl 2000;59:59-68.
225. Havran WL. A role for epithelial gammadelta T cells in tissue repair. Immunol Res 2000;21( 2-3):63-9.
226. Antel J. Regulation of the Immune Response within the Central Nervous System. In:Berczi I, Gorczynski R, editors. Neuroimmune Biology: New Foundation of Biology. Shannon, Co. Clare, Ireland, Elsevier, 2001.
227. Stevens-Felten SY, Bellinger DL. Noradrenergic and peptidergic innervation of lymphoid organs. Chem Immunol 1997;69:99-131.
228. Nance D. Immunoregulation by the sympathetic nervous system. In: Berczi I, Gorczynski R, editors. Neuroimmune Biology: New Foundation of Biology. Shannon, Co. Clare, Ireland, Elsevier, 2001
229. McKay DM, Bienenstock J. The interaction between mast cells and nerves in the gastrointestinal tract. Immunology Today 1994;15:533-538.
230. Derijk RH, Strijbos PJ, van Rooijen N, Rothwell NJ, Berkenbosch F. Fever and thermogenesis in response to bacterial endotoxin involve macrophage-dependent mechanisms in rats. Am J Physiol 1993 Nov 265( 5 Pt 2): R1179-83.
231. Berczi I, Nagy E. Immune-endocrine interactions. In: Stefaneanu L, Sasano H, Kovacs K, editors. Molecular and Cellular Endocrine Pathology. Chapman and Hall, 2000: 425-456.
232. Moldofsky H. Sleep, health and immunocompetence. In: Berczi I, Gorczynski RM, editors. Neuroimmune Biology: New Foundation of Biology. Shannon, Co. Clare, Ireland, Elsevier, 2001
233. Müller EE, Salerno F, Cocchi D, et al. Interaction between the thyrotropin releasing hormone-induced growth hormone rise and dopaminergic drugs: Studies in pathological conditions in the animal and man. Clin Endocrinol 1979; 11: 645-56.
234. Van den Berghe G, de Zegher F, Vlasselaers D, Schetz M, Verwaest C, Ferdinande P, Lauwers P. Thyrotropin - releasing hormone in critical illness: From a dopamine - dependent test to a strategy for increasing low serum triiodothyronine, prolactin, and growth hormone concentrations. Crit Care Med 1996;24:590-5.
235. Li S, Crenshaw EB III, Rawson EJ, Simmons DM, Swanson LW, Rosenfeld MG. Dwarf locus mutants lacking three pituitary cell types result from mutations in the POU-domain gene pit-1. Nature 1990;347:528-33.
236. Castro PR, Penalva R, Pereda MP, Renner U, Reul JMHM, Stalla GK, Holsboer F, Arzt E.Early activation of thyrotropin-releasing-hormone and prolactin plays a critical role duringa T cell-dependent immune response. Endocrinology 1999;130:690-97.
237. Raiden S, Polack E, Nahmod V, Labeur M, Holsboer F, Larzt E. TRH receptor on immune cells: in vitro and in vivo stimulation of human lymphocyte and rat splenocyte DNA synthesis by TRH. J Clin Immunol 1995;15:242-9.
238. Wang J, Klein JR. Thymus-neuroendocrine interactions in extrathymic T cell development. Science 1994;265:1860-1862.
239. Komorowski J, Zylinska K, Pawlikowski M, Stepien H. Stimulatory effect of thyrotropin (TSH) on interleukin-2 (IL-2) release from human peripheral blood lymphocytes. A dose-response study in vitro. Hormones Metab Res 1993;25:598-599.
240. Nicoll CS. Prolactin and growth hormone: Specialists on one hand and mutual mimics on the other. Perspect Biol Med 1982;25:369-381.
241. Berczi I. The immunology of prolactin. Semin Reprod Endocrinology 1992;10:196-219.
242. Lewis UJ. Growth hormone -What is it and what does it do. Trends Endocrinol Metab 1992;3:117-121.
243. Southard JN, Talamantes F. Placental prolactin-like proteins in rodents -Variations on a structural theme. Mol Cell Endocrinology 1991;79:C133-130.
244. Nickel BE, Kardami E, Cattini PA. The human placental growth hormone variant is mitogenic for rat lymphoma Nb2 cells. Endocrinology 1990;126:971-976.
245. Duckworth ML, Robertson MC, Schroedter IC, Szpirer C, Friesen HG. Molecular genetics and biology of the rat placental prolactin family. In: Soares MJ, Handwerger S, Talamantes F, editors. Trophoblast cells: pathways for maternal-embryonic communication. New York: Springer, 1993;169-190.
246. Berczi I, Chalmers IM, Nagy N, Warrington RJ. The immune effects of neuropeptides.Bailliere Clin Rheumatol 1996;10:227-257.
247. Rohn WM, Weigent DA. Cloning and nucleotide sequencing of rat lymphocyte growth hormone cDNA. Neuroimmunomodulation 1995;2:108-14.
248. Palmetshofer A, Zechner D, Luger TA, Barta A. Splicing variants of the human growth hormone mRNA: detection in pituitary, mononuclear cells and dermal fibroblasts. Mol Cell Endocrinology 1995;113:225-34.
249. Sabharwal P, Varma S. Growth hormone synthesized and secreted by human thymocytes acts via insulin-like growth factor I as an autocrine and paracrine growth factor. J Clin Endocrinol Metab 1996;81:2663-9.
250. Matera L. Endocrine, paracrine and autocrine actions of prolactin on immune cells. Life Sci 1996;59:599-614.
251. Kelly PA, Djiane J, Postel-Vinay MC, Edery M. The prolactin/ growth hormone receptor family. Endocr Rev 1991;12:235-251.
252. Wells JA, de Vos AM. Structure and function of human growth hormone: Implications for the hematopoietins. Annu. Rev Biophys. Biomol Struct. 1993;22:329-351.
253. Kishimoto T, Taga T, Akira S. Cytokine signal transduction. Cell 1994;76:253-262.
254. Ihle JN. The Janus kinase family and signaling through members of the cytokine receptor superfamily. Proc Soc Exp Biol Med 1994;206:268-72.
255. Rui H, Djeu JY, Evans GA, Kelley PA, Farrar WL. Prolactin receptor triggering: Evidence for rapid tyrosine kinase activation. J Biol Chem. 1992;267:23076-23081.
256. Clevenger CV, Sillman AL, Prystowsky MB. Interleukin-2 driven nuclear translocation of prolactin in cloned lymphocytes-T. Endocrinology 1990;127:3151-3159.
257. Horseman ND, Yu-Lee LY. Transcriptional regulation by the helix bundle peptide hormones: growth hormone, prolactin, and hematopoietic cytokines. Endocrine Rev 1994;15:627-649.
258. Berczi I. Pituitary hormones and immune function, Acta Paediatr. (Suppl) 1997;423:30-75.
259. Potter EL, Craig JM. Pathology of the Fetus and the Infant. 3rd edition. Chicago, Year Book, 1975.
260. Arezzini C, De Gori V, Tarli P, Neri P. Weight increase of body and lymphatic tissues in dwarf mice treated with human chorionic somatomammotropin (HCS). Proc Soc Exp Biol Med 1972;141:98-100.
261. Berczi I, Nagy E. Human placental lactogen is a hemopoietic hormone. Br J Haematol. 1991;79:355-358.
262. Berczi I, Nagy E. The effect of prolactin and growth hormone on hemolymphopoietic tissue and immune function. In: Berczi I, Kovacs K, editors. Hormones and Immunity. Lancaster, England, MTP Press, 1987;145-171.
263. Berczi I. The role of the growth and lactogenic hormone family in immune function. Neuroimmunomodulation. 1994;1:201-216.
264. Bellone G, Geuna M, Carbone A, Silvestri S, Foa R, Emanuelli G, et al. Regulatory actionof prolactin on the in vitro growth of CD34+ ve human hemopoietic progenitor cells. J Cell Physiol 1995;163:221-31.
265. Merchav S, Tatarsky I, Hochberg Z. Enhancement of erythropoiesis in vitro by human growth hormone is mediated by insulin-like growth factor-I. Br J Haematol 1988;30:267-271.
266. Merchav S, Tatarsky I, Hochberg Z. Enhancement of human granulopoiesis in vitro by biosynthetic insulin-like growth factor I/ somatomedin C and human growth hormone. J. Clin. Invest 1988;81:791-797.
267. Kelley KW, Arkins S, Minshall C, Liu Q, Dantzer R. Growth hormone, growth factors and hematopoiesis. Hormone Res 1996;45:38-45.
268. Kelley KW, Brief S, Westly HJ, Novakofski J, Bechtel PJ, Simon J, Walker EB. GH 3 pituitary adenoma cells can reverse thymic aging in rats. Proc Natl Acad Sci USA 1986;83:5663-5667.
269. Berczi I, Nagy E, De Toledo SM, Matusik RJ, Friesen HG. Pituitary hormones regulate c-myc and DNA synthesis in lymphoid tissue. J Immunol 1991;146:2201-2206.
270. Beschorner WE, Divic J, Pulido H, Yao X, Kenworthy P, Bruce G. Enhancement of thymic recovery after cyclosporine by recombinant human growth hormone and insulin-like growth factor-I. Transplantation 1991;52:879-884.
271. Binz K, Joller P, Froesch P, Binz H, Zapf J, Froesch ER. Repopulation of the atrophied thymus in diabetic rats by insulin-like growth factor I. Proc Natl Acad Sci USA 1990;87:3690-3694.
272. Timsit J, Savino W, Safi eh B, Chanson P, Gagnerault MC, Bach JF, Dardenne M. Growth hormone and insulin-like growth factor-I stimulate hormonal function and proliferation of thymic epithelial cells. J Clin Endocrinol Metab 1992;75:183-188.
273. Kaplan SL, Grumbach MM, Friesen HG, Costom BH. Thyrotropin-releasing factor (TRF) effect on secretion of human pituitary prolactin and thyrotropin in children and in idiopathic hypopituitary dwarfi sm: further evidence for hypophysiotropic hormone deficiencies. J Clin Endocrinol Metab 1972;35:825-830.
274. Spangelo BL, Hall NRS, Ross PC, Goldstein AL. Stimulation of in vivo antibody production and concanavalin-A-induced mouse spleen cell mitogenesis by prolactin. Immunopharmacology 1987;14:11-20.
275. Cross RJ, Campbell JL, Markesbery WR, Roszman TL. Transplantation of pituitary grafts fail to restore immune function and to reconstitute the thymus glands of aged mice. Mech Age Dev 1990;56:11-22.
276. Cesano A, Oberholtzer E, Contarini M, Geuna M, Bellone G, Matera L. Independent and synergistic effect of interleukin-2 and prolactin on development of T-and NK-derived LAK effectors. Immunopharmacology 1994;28:67-75.
277. Bozzola M, Valtorta A, Moretta A, Cisternino M, Biscaldi I, Schimpff RM. In vitro and in vivo effect of growth hormone on cytotoxic activity. J Pediat1990;117:596-599.
278. Rovensky J, Ferencikova J, Vigas M, Lukac P. Effect of growth hormone on the activity of some lysosomal enzymes in neutrophilic polymorphonuclear leukocytes of hypopituitary dwarfs. Int J Tissue React 1985;7:153-159.
279. Wiedermann CJ, Niedermuhlbichler M, Beimpold, Braunsteiner H. In vitro activation of neutrophils of the aged by recombinant human growth hormone. J Infect Dis 1991; 164:1017-1020.
280. Manfredi R, Tumietto F, Azzaroli L, Zucchini A, chiodo F, Manfredi G. Growth hormone (GH) and the immune system: impaired phagocytic function in children with idiopathic GH deficiency is corrected by treatment with biosynthetic GH. J Pediat Endocrinol 1994;7:245-251.
281. Cecilia-Fornari M, Fernanda-Palacios M, Diez RA, Intebi AD. Decreased chemotaxis of neutrophils in acromegaly and hyperprolactinemia. Eur J Endocrinology 1994;130: 463-468.
282. Rapaport R. Immunomodulation by growth hormone in humans. In: Berczi I, Szelenyi J, editors. Advances in Psychoneuroimmunology. New York: Plenum Press, 1994:83-98.
283. Galdiero M, Donnarumma G, Cipollareo de l'Ero G, Marcatili A, Scarfogliero P, Sommese L. Effect of growth hormone, prolactin and insulin on the release of IL-1 alpha, IFN-gamma and IL-4 by staphylococcal enterotoxin A-stimulated splenocytes. Eur Cytokine Netw 1995;6:187-94.
284. LeRoith D, Yanowski J, Kaldjian EP, Jaffe ES, LeRoith T, Purdue K, Cooper BD, Pyle R, Adler W. The effects of growth hormone and insulin-like growth factor I on the immune system of aged female monkeys. Endocrinology 1996;137:1071-9.
285. Gelato MC. Aging and immune function: a possible role for growth hormone. Hormone Res 1996;45:46-9.
286. Dorshkind K, Horseman ND. The roles of prolactin, growth hormone, insulin-like growth factor-I, and thyroid hormones in lymphocyte development and function. Insights from genetic models of hormone and hormone receptor deficiency. Endocrine Rev 2000; 21:292-312.
287. Bole-Feysot C, Goffi n V, Edery M, Binart N and Kelly PA. Prolactin (PRL) and its receptor: Actions, signal transduction pathways and phenotypes observed in PRL-receptor knockout mice. Endocrine Rev 1998;19:225-68.
288. Nagy E, Berczi I. Hypophysectomized rats depend on residual prolactin for survival. Endocrinology 1991;146:2776-2784.
289. Komorowski J, Stepien H, Pawlikowski M. The evidence of thyroliberin/ triiodothyronine control of TSH secretory response from human peripheral blood monocytes cultured in vitro. Neuropeptides 1993;25:31-4.
290. Bagriacik EU, Klein JR. The thyrotropin (thyroid-stimulating hormone) receptor is expressed on murine dendritic cells and on a subset of CD45RBhigh lymph node T cells: functional role for thyroid-stimulating hormone during immune activation. J Immunol 2000;Jun 15;164( 12): 6158-65.
291. Hsu J-H, Brent GA. Thyroid hormone receptor gene knock outs. Trends Endocrinol Metab 1998;9:103-111.
292. Fabris N, Mocchegiani E, Provinciali M. Pituitary-thyroid axis and immune system: a reciprocal neuroendocrine - immune interaction. Hormone Res 1995;43:29-38.
293. Berczi I. The influence of pituitary-adrenal axis on the immune system. In: Berczi I, editor. Pituitary Function and Immunity. Boca Raton, Florida, CRC Press, 1986:49-132.
294. Besedovsky HO, del Rey A, Klusman I, Furukawa H, Monge-Arditi G, Kabiersch A. Cytokines as modulators of the hypothalamus-pituitary-adrenal axis. J Steroid Biochem. Mol Biol 1991;30:613-618.
295. Vamvakopoulos NC, Chrousos GP. Hormonal regulation of human corticotropin-releasing hormone gene expression: implications for the stress response and immune/ inflammatory reaction. Endocrine Rev 1994;15:309-420.
296. Heijnen CJ, Zijlstra J, Kavelaars A, Croiset G, Ballieux RE. Modulation of the immune response by POMC-derived peptides. I. Influence on proliferation of human lymphocytes. Brain Behav Immun 1987;1:284-291.
297. Catania A, Airaghi L, Colombo G, Lipton JM. Alpha-Melanocyte-stimulating Hormone in Normal Human Physiology and Disease States. Trends Endocrinol Metab 2000; Oct 1;11( 8):304-308.
298. Stein C, Schafer M, Hassan AHS. Peripheral opioid receptors. Ann Med 1995;27:219-221.
299. Taub DD, Eisenstein TK, Geller EB, Adler MW, Rogers TJ. Immunomodulatory activity of µ-and -selective opioid agonists. Proc Natl Acad Sci USA 1991;88:360-364.
300. Alicea C, Belkowski S, Eisenstein TK, Adler MW, Rogers TJ. Inhibition of primary murine macrophage cytokine production in vitro following treatment with the -opioid agonist U50, 488H. J Neuroimmunol 1996;64:83-90.
301. Blalock JE. Proopiomelanocortin and the immune - neuroendocrine connection. Ann N Y Acad Sci 1999;Oct 20;885:161-72.
302. Catania A, Lipton JM. The neuropeptide alpha - melanocyte -stimulating hormone: a key component of neuroimmunomodulation. Neuroimmunomodulation. 1994; 93-99.
303. Shimizu T, Streilein JW. Infl uence of alpha-melanocyte stimulating hormone on induction of contact hypersensitivity and tolerance. J Dermatol Sci 1994;8:187-193.
304. Grabbe S, Bhardwaj RS, Mahnke K, Simon MM, Schwarz T, Luger TA. Alpha-melanocyte-stimulating hormone induces hapten-specific tolerance in mice. J Immunol1996;156:473-478.
305. King LB, Vacchio MS, Dixon K, Hunziker R, Margulies DH, Ashwell JD. A targeted glucocorticoid receptor antisense transgene increases thymocyte apoptosis and alters thymocyte development. Immunity 1995;3:647-656.
306. Wiegers GJ, Labeur MS, Stec IEM, Klinkert WEF, Holsboer F, Reul JMHM. Glucocorticoids accelerate anti-T cell receptor-induced T cell growth. J Immunol 1995; 155:1893-1902.
307. Munck A, Naray-Fejes-Toth A, Guyre PM. Mechanisms of glucocorticoid actions on the immune system. In: Berczi I, Kovacs K, editors. Hormones and Immunity. Lancaster, England: MTP Press Ltd, 1987.
308. Vacchio MS, Papadopoulos V, Ashwell JD. Steroid production in the thymus: implications for thymocyte selection. J Exp Med 1994;179:1835-46.
309. Rook GA. Glucocorticoids and immune function. Baillieres Best Pract Res Clin Endocrinol Metab 1999;Dec;13 ( 4):567-81.
310. Ashwell JD, Lu FW, Vacchio MS. Glucocorticoids in T cell development and function. Annu. Rev Immunol 2000;18:309-45.
311. Grasso G, Massai L, De Leo V, Muscettola M. The effect of LHRH and TRH on human interferon-gamma production in vivo and in vitro. Life Sci 1998;62( 22):2005-14.
312. Athreya BH, Pletcher J, Zulian F, Weiner DB, Williams WV. Subset-specifi c effects of sex hormones and pituitary gonadotropins on human lymphocyte proliferation in vitro. Clin Immunol ImmunoPathol 1993;66:201-211.
313. Rouabhia M, Chakir J, Deschaux P. Interaction between the immune and endocrine systems: Immunodulatory effects of luteinizing hormone. Prog NeuroendocrinImmunol 1991;4:86-91.
314. Komorowski J, Stepien H. FSH and LH induce interleukin-6 (IL-6) release from human peripheral blood monocytes cultures in vitro. A dose-response study. Hormone Metab Res 1994;26:438-439.
315. Sullivan DA. Endocrine regulation of the ocular secretory immune system. In: Berczi I, Kovacs K, editors. Hormones and immunity. Lancaster, England, MTP Press, 1987: 54-92.
316. Nelson JL, Steinberg AD. Sex steroids, autoimmunity and autoimmune disease. In: Berczi I, Kovacs, K, editors. Hormones and Immunity. Lancaster, England, MTP Press, 1987:93-119.
317. Nagy E, Baral E, Berczi I. Immune System. In: Oettel M, editor-in-chief. Handbook of Experimental Pharmacology. Estrogens and anti-estrogens. Section IV. Physiology and Pathophysiology of estrogens. Springer-Verlag (in press).
318. Lahita RG. The role of sex hormones in systemic lupus erythematosus. Curr Opin Rheumatol 1999;Sept;11 ( 5):352-6.
319. Muller D, Chen M, Vikingsson A, Hildeman D, Pederson K. Oestrogen influences CD4 + T-lymphocyte activity in vivo and in vitro in 2-microglobulin-deficient mice. Immunology 1995;86:162-7.
320. Ahmed SA, Talal N, Christadoss P. Genetic regulation of testosterone-induced immune suppression. Cell Immunol 1987;104( 1):91-98.
321. Greenstein BD, de Bridges EF, Fitzpatrick FTA. Aromatase inhibitors regenerate the thymus in aging male rats. Int J Immunopharm 1992;14:541-53.
322. Araneo BA, Dowell T, Diegel M, Daynes RA. Dihydrotesterone exerts a depressive influence on the production of interleukin-4 (IL-4), IL-5, and gamma - interferon, but not IL-2 by activated murine T cells. Blood 1991;78:688-99.
323. Konstadoulakis MM, Syrigos KN, Baxevanis CN, Syrigou EI, Papamichail M, Peveretos P, Anapliotou M, Golematis BC. Effect of testosterone administration, pre-and postnatally, on the immune system of rats. Horm Metab Res 1995;27:275-8.
324. Regelson W, Loria R, Kalimi M. Dehydroepiandrosterone (DHEA) -the "mother steroid." I. Immunologic action. Ann NY Acad Sci 719:553-63.
325. Catania RA, Angele MK, Ayala A, Cioffi WG, Bland KI, Chaudry IH. Dehydroepiandro-sterone restores immune function following trauma-haemorrhage by a direct effect on T lymphocytes. Cytokine 1999;Jun;11( 6):443-50.
326. Padgett DA, Loria RM. In vitro potentiation of lymphocyte activation by dehydroepiandro-sterone, androstenediol, and androstenetriol. J Immunol 1994;153: 1544-52.
327. Suzuki T, Suzuki N, Daynes RA, Engleman EG. Dehydroepiandrosterone enhances IL2 production and cytotoxic effector function of human T cells. Clin Immunol ImmunoPathol 1991;61:202-11.
328. Weksler ME. Immune senescence and adrenal steroids: immune dysregulation and the action of dehydroepiandrosterone (DHEA) in old animals. Eur J Clin Pharmacol 1993;45:S21-3.
329. Loria RM, Padgett DA, Huynh PN. Regulation of the immune response by dehydroepiandro-sterone and its metabolites. J Endocrinol 1996;150:S209-20.
330. Check JH, Tarquini P, Gandy P, Lauer C. A randomized study comparing the efficacy of reducing the spontaneous abortion rate following lymphocyte immunotherapy and progesterone treatment versus progesterone alone in primary habitual aborters. Gynecol Obstet Invest 1995;39:257-61.
331. Fleming MW, Gamble HR. Consequences of dose-dependent immunosuppression by progesterone on parasitic worm burdens in lambs. Am J Vet Res 1993;54:1299-302.
332. Parr MB, Kepple L, McDermott MR, Drew MD, Bozzola JJ, Parr EL. A mouse model for studies of mucosal immunity to vaginal infection by herpes simplex virus type 2. Lab Invest 1994;30:369-80.
333. Kalo-Klein A, Witkin SS. Regulation of the immune response to Candida albicans by monocytes and progesterone. Am J Obstet Gynecol 1991;164:1351-4.
334. Nohmi T, Abe S, Dobashi K, Tansho S, Yamaguchi H. Suppression of anti-Candida activity of murine neutrophils by progesterone in vitro: a possible mechanism in pregnant women's vulnerability to vaginal Candidiasis. Microbiol Immunol 1995;39:305-9.
335. Li ZG, Danis VA, Brooks PM. Effect of gonadal steroids on the production of IL-1 and IL-6 by blood mononuclear cells in vitro. Clin Exp Rheumatol 1993;11:157-62.
336. Szekeres-Bartho J, Barakonyi A, Polgar B, Par G, Faust Z, Palkovics T, Szereday The role of gamma/ delta T cells in progesterone-mediated immunomodulation during pregnancy: a review. Am J Reprod Immunol 1999;Jul;42( 1):44-8.
337. Manolagas SC, Yu XP, Girasole G, Bellido T. Vitamin D and the hematolymphopoietic tissue: a 1994 update. Sem Nephrol 1994;14:129-43.
338. Bouillon R, Garmyn M, Verstuyf A, Segaert S, Casteels K, Mathieu C. Paracrine role for calcitriol in the immune system and skin creates new therapeutic possibilities for vitamin D analogs. Eur J Endocrinology 1995;133:7-16.
339. Yang S, Smith C, Prahl JM, Luo X, DeLuca HF. Vitamin D deficiency suppresses cell-mediated immunity in vivo. Arch Biochem. Biophys. 1993;303:98-106.
340. Piemonti L, Monti P, Sironi M, Fraticelli P, Leone BE, Dal Cin E, Allavena P, Di Carlo V. Vitamin D3 affects differentiation, maturation, and function of human monocyte-derived dendritic cells. J Immunol 2000;May 1;164( 9):4443-51.
341. Daynes RA, Enioutina EY, Butler S, Mu HH, McGee ZA, Araneo BA. Induction of common mucosal immunity by hormonally immunomodulated peripheral immunization. Infect Immun 1996;64:1100-9.
342. Casteels K, Bouillon R, Waer M, Mathieu C. Immunomodulatory effects of 1, 25-dihydroxy-vitamin D3. Curr Opin Nephrol Hypertens 1995;4:313-8.
343. Branisteanu DD, Waer M, Sobis H, Marcelis S, Vandeputte M, Bouillon R. Prevention of murine experimental allergic encephalomyelitis: cooperative effects of cyclosporine and 1á, 25-( OH) 2 D 3 . J Neuroimmunol 1995;61:151-60.
344. Lemire J, 1, 25-Dihydroxyvitamin D3--a hormone with immunomodulatory properties. Z Rheumatol 2000;59 Suppl 1:24-7.
345. Shedpure M, Pati AK. The pineal gland: structural and functional diversity. Indian J Exp Biol 1995;33:625-30.
346. Roberts JE. Visible light induced changes in the immune response through an eye-brain mechanism (photoneuroimmunology). J Photochem Photobiol B Biol 1995;29:3-15.
347. Morrey KM, McLachlan JA, Serkin CS, Bakouche O. Activation of human monocytes by the pineal hormone melatonin. J Immunol 1994;153:2671-80.
348. DiStefano A, Paulesu L. Inhibitory effect of melatonin on production of IFN - gamma or TNF - alpha in peripheral blood mononuclear cells of some blood donors. J Pineal Res 1994;17:164-169.
349. Giordano M, Vermeulen M, Palermo MS. Seasonal variations in antibody-dependent cellular cytotoxicity regulation by melatonin. Int J Neurosci 1993;68:109-25.
350. Mocchegiani E, Bulian D, Santarelli L, Tibaldi A, Mozzioli M, Pierpaoli W, Fabris N. The immuno-reconstituting effect of melatonin or pineal grafting and its relation to zinc pool in aging mice. J Neuroimmunol 1994;53:189-201.
351. Maestroni GJ. MLT and the immune-hematopoietic system. Adv. Exp Med. Biol 1999;460:395-305.
352. Nelson RJ, Drazen DL. Melatonin mediates seasonal adjustments in immune function. Reprod Nutr Dev 1999;May-Jun;39( 3):383-98.
353. Levi-Montalcini R. The nerve growth factor, its mode of action on sensory and sympathetic,nerve cells. Harvey Lectures 1966;60:217-259.
354. Pezzati P, Stanisz AM, Marshall JS, Bienenstock J, Stead RH. Expression of nerve growth factor receptor immunoreactivity on follicular dendritic cells from human mucosa associated lymphoid tissues. Immunology 1992;76:485-490.
355. Lomen-Hoerth C, Shooter EM. Widespread neurotrophin receptor expression in the immune system and other nonneuronal rat tissues. J Neurochem 1995;64:1780-9.
356. Cosman D. A family of ligands for the TNF receptor superfamily. Stem Cells Dayt 1994;12:430-55.
357. Franklin RA, Brodie C, Melamed I, Tereda N, Lucas JJ, Gelfand EW. Nerve growth factor induces activation of MAP-kinase and p90 rsk in human B lymphocytes. J Immunol 1995;154:4965-4972.
358. Manning PT, Russell JH, Simmons B, Johnson EM. Protection from guanethidine-induced neuronal destruction by nerve growth factor: effect of NGF on immune function. Brain Res 1985;330:61-69.
359. Otten U, Ehrhard P, Peck R. Nerve growth factor induces growth and differentiaton of human B lymphocytes. Proc Natl Acad Sci USA 1989;86:10059-10063.
360. Kimata H, Yoshida A, Ishioka C, Kusunoki T, Hosoi S, Mikawa H. Nerve growth factor specifically induces human IgG4 production. Eur J Immunol 1991;21:137-141.
361. Brodie C, Oshiba A, Renz H, Bradley K, Gelfand EW. Nerve growth factor and anti-CD30 provide opposite signals for the production of IgE in inteleukin-4-treated lymphocytes. Eur J Immunol 1996;26:171-8.
362. Santambrogio L, Benedetti M, Chao MV, Muzaffar R, Kulig K, Gabellini N, Hochwald G. Nerve growth factor production by lymphocytes. J Immunol 1994;153:4488-95.
363. Leon A, Buriani A, DalToso R, et al. Mast cells synthesize, store, and release nerve growth factor. Proc Natl Acad Sci USA 1994;91:3739-43.
364. Aloe L, Levi-Montalcini R. Mast cells increase in tissues of neonatal rats injected with the nerve growth factor. Brain Res 1977;133:358-366.
365. Bohm A, Aloe L, Levi-Montalcini R. Nerve growth factor enhances precocious differentiation and numerical increase in mast cells in cultures of rat splenocytes. Acad Naz Lineei 1986;80:1.
366. Marshall JS, Stead RH, McSharry C, Nielsen L, Bienenstock J. The role of mast cell degranulation products in mast cell hyperplasia. I. Mechanism of action of nerve growth factor. J Immunol 1990;144:1886-1892.
367. Bischoff SC, Dahinden CA. Effect of nerve growth factor on the release of inflammatory mediators by mature human basophils. Blood 1992;79:2662-2669.
368. Garaci E, Caroleo MC, Aloe L, Aqaro S, Piacentini M, Costa N, Amendola A, Micera A, Calio R, Perno CF, Levi-Montalcini R. Nerve growth factor is an autocrine factor essential for the survival of macrophages infected with HIV. Proc Nat Acad Sci USA 1999;96:13013-8.
369. Gee AP, Boyle MDP, Munger KL, Lawman MJ, Young M. Nerve growth factor: stimulation of polymorphonuclear leukocyte chemotaxis in vitro. Proc Natl Acad Sci USA 1983;80:7215-7218.
370. Boyle MDP, Lawman MJP, Gee AP, Young M. Nerve growth factor: a chemotactic factor for polymorphonuclear leukocytes in vivo. J Immunol 1985;135:564-568.
371. Banks BEC, Vernon CA, Warner JA. Nerve growth factor has anti-inflammatory activity in the rat hind paw oedema test. Neurosci Lett 1984;47:41-45.
372. Amico-Roxas M, Caruso A, Leone MG, Scifo R, Vanella A, Scapagnini U. Nerve growth factor inhibits some acute experimental inflammations. Arch Int Pharmacodyn Ther 1989;299:269-285.
373. Braun A, Appel E, Baruch R, Herz U, Botchkarev V, Paus R, Brodie C, Renz H. Role of nerve growth factor in a mouse model of allergic airway inflammation and asthma. Eur J Immunol 1998;Oct;28( 10):3230-51.
374. Kerschensteiner M, Gallmeier E, Behrens L, Leal VV, Misgeld T, Klinkert WE, Kolbeck R, Hoppe E, Oropeza-Wekerle RL, Bartke I, Stadelmann C, Lassmann H, Wekerle H, Hohlfeld R. Activated human T cells, B cells, and monocytes produce brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: a neuroprotective role of inflammation? J Exp Med 1999;Mar 1;189( 5):865-30.
375. Besser M, Wank R. Cutting edge: clonally restricted production of the neurotrophins brain-derived neurotrophic factor and neurotrophin-3 mRNA by human immune cells and Th1/ Th2-polarized expression of their receptors. Immunol 1999;Jun 1;162( 11):6303-6.
376. Simone MD, De Santis S, Vignetti E Papa G, Amadori S, Aloe L. Nerve growth factor: a survey of activity on immune and hematopoietic cells. Hematol Oncol 1999;1:1-10.
377. Hohlfeld R, Kerschensteiner M, Stadelmann C, Lassmann H, Wekerle H. The neuroprotective effect of inflammation: implications for the therapy of multiple sclerosis. J Neuroimmunol 2000;Jul 24;107( 2):161-6.
378. Reinshagen M, Rohm H, Steinkamp M, Lieb K, Geerling I, Von Herbay A, Flamig G, Eysselein VE, Adler G. Protective role of neurotrophins in experimental inflammation of the rat gut. Gastroenterology. 2000;Aug;119( 2):368-76.
379. Moalem G, Gdalyahu A, Shani Y, Otten U, Lazarovici P, Cohen IR, Schwartz M. Production of Neurotrophins by Activated T Cells: Implications for Neuroprotective Autoimmunity. J Autoimmun 2000;Nov;15( 3):331-345.
380. Lord GM, Matarese G, Howard JK, Baker RJ, Bloom SR, Lechler RI. Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature 1998; Aug 27;394( 6696):897-901.
381. Bornstein SR, Licinio J, Tauchnitz R, Engelmann L, Negrao AB, Gold P, Chrousos GP. Plasma leptin levels are increased in survivors of acute sepsis: associated loss of diurnal rhythm, in cortisol and leptin secretion. J Clin Endocrinol Metab 1998;Jan;83( 1): 280-3.
382. Wauters M, Considine RV, Van Gaal LF. Human leptin: from an adipocyte hormone to an endocrine mediator. Eur J Endocrinol 2000;Sept;143( 3):293-311.
383. Hosoi T, Okuma Y, Nomura Y. Expression of leptin receptors and induction of IL-1beta transcript in glial cells. Biochem Biophys Res Commun 2000;Jun 24;273( 1): 312-5.
384. Faggioni R, Moser A, Feingold KR, Grunfeld C. Reduced leptin levels in starvation increase susceptibility to endotoxic shock. Am J Pathol 2000;May;1 56( 5):1781-7.
385. Matarese G. Leptin and the immune system: how nutritional status influences the immune response. Eur Cytokine Netw 2000;Mar;11( 1):7-14.
386. Giovambattista A, Chisari AN, Corro L, Gaillard RC, Spinedi E. Metabolic, neuroendocrine and immune functions in basal conditions and during the acute-phase response to endotoxic shock in undernourished rats. Neuroimmunomodulation 2000;7( 2): 92-8.
387. Okamoto S, Irie Y, Ishikawa I, Kimura K, Masayuki Saito. Central leptin suppresses splenic lymphocyte functions through activation of the corticotropin-releasing hormone - sympathetic nervous system. Brain Res 2000;Feb 7;855 ( 1):192-7.
388. Chautard T, Spinedi E, Voirol M, Pralong FP, Gaillard RC. Role of glucocorticoids in the response of the hypothalamo-corticotrope, immune and adipose systems to repeated endotoxin administration. Neuroendocrinology 1999;May;69( 5):360-9.
389. Torpy DJ, Bornstein SR, Chrousos GP. Leptin and interleukin-6 in sepsis. Horm Metab Res 1998; Dec;30 (12):726-9.
390. Faggioni R, Fantuzzi G, Gabay C, Moser A, Dinarello CA, Feingold KR, Grunfeld C. Leptin deficiency enhances sensitivity to endotoxin-induced lethality. Am J Physiol 1999; Jan; 276( 1 Pt 2):R136-42.
391. Takahashi N, Waelput W, Guisez Y. Leptin is an endogenous protective protein against the toxicity exerted by tumor necrosis factor. J Exp Med 1999;Jan 4;189( 1):207-12.
392. Finck BN, Kelley KW, Dantzer R, Johnson RW. In vivo and in vitro evidence for the involvement of tumor necrosis factor-alpha in the induction of leptin by lipopolysaccharide. Endocrinology 1998;May;139( 5): 2278-83.
393. Loffreda S, Yang SQ, Lin HZ, Karp CL, Brengman ML, Wang DJ, Klein AS, BulkleyGB, Bao C, Noble PW, Lane MD, Diehl AM. Leptin regulates proinflammatory immune responses. FASEB J 1998;Jan;12( 1):57-65.
394. Fantuzzi G, Faggioni R. Leptin in the regulation of immunity, inflammation, and hematopoiesis. J Leukoc Biol 2000;Oct;68( 4):437-46.
395. Barach EM, Nowak RM, Lee TG, Tomlanovich MC. Epinephrine for treatment of anaphylactic shock. JAMA. 1984;251( 16):2118-2122.
396. Nelson HS. Adrenergic therapy of bronchial asthma. J Allergy Clin Immunol 1986;77( 6):71-785.
397. Livnat S, Felten SY, Carlson DL, Bellinger FL, Felten DL. Involvement of peripheral and central catecholamine systems in neural-immune interactions. J Neuroimmunol 1985; 10:5-30.
398. Cross RJ, Jackson JC, Brooks WH, Sparks DL, Markesbery WR, Roszman TL. Neuroimmunomodulation: Impairment of humoral immune responsiveness by 6-hydroxy-dopamine treatment. Immunology 1986;57( 1):145-152.
399. Berczi I, Nagy E. Neurohormonal control of cytokines during injury. In: Rothwell NJ, Berkenbosch F, editors. Brain Control of Responses to Trauma. Cambridge University Press, 1994:32-107.
400. Schauenstein K, Rinner I, Felsner P, et al. The role of the adrenergic/ cholinergic balance in the immune - neuroendocrine circuit. In: Berczi I, Szelenyi J, editors. Advances in psychoneuroimmunology. New York, Plenum Press, 1994:349-356.
401. Nagatomi R, Kaifu T, Okutsu M, Zhang X, Kanemi O, Ohmori H. Modulation of the immune system by the autonomic nervous system and its implication in immunological changes after training. Exerc Immunol Rev 2000;6:54-74.
402. Szelenyi J, Kiss JP, Vizi ES. Differential involvement of sympathetic nervous system and immune system in the modulation of TNF-alpha production by alpha2-and beta-adrenoceptors in mice. J Neuroimmunol 2000;Feb 1;103( 1):34-30.
403. Bergmann M, Gornikiewicz A, Sautner T, Waldmann E, Weber T, Mittlbock M, Roth E, Fugger R. Attenuation of catecholamine-induced immunosuppression in whole blood from patients with sepsis. Shock 1999 Dec;12( 6):421-7.
404. Schauenstein K, Rinner I, Felsner P, et al. The role of the adrenergic/ cholinergic balance in the immune - neuroendocrine circuit. In: Berczi I, Szelenyi J, editors. Advances in psychoneuroimmunology. New York, Plenum Press, 1994:349-356.
405. Druce HM, Wright RH, Kossoff D, Kaliner MA. Cholinergic nasal hyperreactivity in atopic subjects. J Allergy Clin Immunol 1985;76:445-452.
406. Coffey RG, Hadden JW. Neurotransmitters, hormones, and cyclic nucleotides in lymphocyte regulation. Fed Proc 1985;44( 1):112-117.
407. Szelenyi J, Ha NTH. Expression of cholinergic structure on lymphocytes. In: Berczi I, Szelenyi J, editors. Advances in psychoneuroimmunology. New York, Plenum Press, 1994:271-277.
408. Payan DG, McGillis JP, Renold FK, Mitsuhashi M, Goetzl EJ. The immunomodulating properties of neuropeptides. In: Berczi I, Kovacs K, editors. Hormones and immunity. Lancaster, England, MTP Press, 1987.
409. Foreman JC. Neuropeptides and the pathogenesis of allergy. Allergy 1987;42( 1):1-11.
410. Shanahan F, Lee TDG, Bienenstock J, Befus AD. Mast cell heterogeneity: Effect of anti-allergic compounds on neuropeptide-induced histamine release. Int Arch Allergy Appl Immunol 1986;80( 4):424-426.
411. Jancso G, Obal F Jr, Toth-Kasa I, Katona M, Husz S. The modulation of cutaneous inflammatory reactions by peptide-containing sensory nerves. Int J Tissue React 1985; 7( 6):449-457.
412. Serra M, Bazzoni F, Della Bianca V, Greskowiak M, Rossi F. Activation of human neutrophils by substance P. Effect on oxidative metabolism, exocytosis, cytosolic Ca 2+ concentration and inositol phosphate formation. J Immunol 1988;141:2118-2124.
413. Lotz M, Carson DA, Vaughan JH. Substance P activation of rheumatoid synoviocytes: Neural pathway in pathogenesis of arthritis. Science 1987;235( 4791):893-895.
414. Hartung HP, Heininger K, Schafer B, Toyka KV. Substance P and astrocytes: stimulation of the cyclooxygenase pathway of arachidonic acid metabolism. Fed Am Soc Exp Biol J 1988;2:48-51.
415. Damonneville M, Monte D, Auriault C, Capron A. The neuropeptide substance-P stimulates the effector functions of platelets. Clin Exp Immunol 1990;81:346-351.
416. Rameshar P, Ganea D, Gascon P. Induction of IL-3 and granulocyte-macrophage colony-stimulating factor by substance P in bone marrow cells is partially mediated through the release of IL-1 and IL-6. J Immunol 1994;152:3044-3054.
417. Mariott I, Bost KL. IL-4 and IFN-gamma up-regulate substance P receptor expression in murine peritoneal macrophages. J Immunol 2000;Jul 1;165( 1):182-91.
418. Blum AM, Metwali A, Kim-Miller M, Li J, Qadir K, Elliott DE, Lu B, Fabry Z, Gerard N, Weinstock JV. The substance P receptor is necessary for a normal granulomatous response in murine schistosomiasis mansoni. J Immunol 1999;May 15;162( 10):6080-5.
419. Bienenstock J. A model of neuroimmune communication: Mast cells and nerves. In: Neuroimmune Biology: New foundation of Biology. Berczi I, Gorczynski R, editors. Shannon, Co. Clare, Ireland, Elsevier, 2001.
420. Mullins MW, Ciallella J, Rangnekar V, McGillis JP. Characterization of a calcitonin gene-related peptide (CGRP) receptor on mouse bone marrow cells. Regul Pept 1993; 49:65-72.
421. Nong YH, Titus RG, Ribeiro JMC, Remold HG. Peptides encoded by the calcitonin gene inhibit macrophage function. J Immunol 1989;145:45-49.
422. Wang X, Fiscus RR, Tang Z, et al. CGRP in the serum of endotoxin-treated rats suppresses lymphoproliferation. Brain Behav Immun 1994;8:282-292.
423. Hosoi J, Murphy GF, Egan CL, et al. Regulation of Langerhans cell function by nerves containing calcitonin gene-related peptide. Nature 1993;363:159-63.
424. Asahina A, Hosoi J, Beissert S, Stratigos A, Granstein RD. Inhibition of the induction of delayed-type and contact hypersensitivity by calcitonin gene-related peptide. J Immunol 1995;154:3056-61.
425. Millet I, Phillips RJ, Sherwin RS, Ghosh S, Voll RE, Flavell RA, Vignery A, Rincon M. Inhibition of NF-kappaB activity and enhancement of apoptosis by the neuropeptide calcitonin gene-related peptide. J Biol Chem 2000;May 19;275( 20):15114-21.
426. Wang X, Xing L, Xing Y, Tang Y, Han C. Identification and characterization of immuno-reactive calcitonin gene-related peptide from lymphocytes of the rat. J Neuroimmunol 1999;Feb 1;94( 1-2):95-102.
427. Streilein JW, Alard P, Niizeki H. A new concept of skin-associated lymphoid tissue (SALT): UVB light impaired cutaneous immunity reveals a prominent role for cutaneous nerves. Keio J Med 1999;Mar; 48( 1):22-7.
428. Foris G, Gyimesi E, Komaromi I. The mechanism of antibody-dependent cellular cytotoxicity stimulation by somatostatin in rat peritoneal macrophages. Cell Immunol 1985;90( 1):217-225.
429. Muscettola M, Grasso G. Somatostatin and vasoactive intestinal peptide reduce interferon gamma production by human peripheral blood mononuclear cells. Immunobiology. 1990;180:419-430.
430. Church MK, El-Lati S, Caulfield JP. Neuropeptide-induced secretion from human skin mast cells. Int Arch Allergy Appl Immunol 1991;94:310-318.
431. Bokum AM, Hofl and LJ, van Hagen PM. Somatostatin and somatostatin receptors in the immune system: a review. Eur Cytokine Netw 2000;Jun;11( 2):161-76.
432. Szolcsanyi J, Helyes Z, Oroszi G, Nemeth J, Pinter E. Release of somatostatin and its role in the mediation of the anti-inflammatory effect induced by antidromic stimulation of sensory fibres of rat sciatic nerve. Br J Pharmacol 1998;Mar; 23( 5):936-42.
433. Ottaway CA. In vitro alterations of receptors for vasoactive intestinal peptide changes the in vivo localization of mouse T cells. J Exp Med 1984;160( 4):1054-1069.
434. O'Dorisio MS. Biochemical characteristics of receptors for vasoactive intestinal polypeptidein nervous endocrine and immune systems. Fed Proc 1987;46( 1):192-195.
435. Kimata H, Fujimoto M. Vasoactive intestinal peptide specifi cally induces human IgA1 and IgA2 production. Eur J Immunol 1994;24:2262-2265.
436. Xin Z, Tang H, Ganea D. Vasoactive intestinal peptide inhibits interleukin (IL)-2 and IL-4 production in murine thymocytes activated via the TCR/ CD3 complex. J Neuroimmunol 1994;54:59-68.
437. Boirivant M, Fais S, Annibale B, Agostini D, Delle Fave G, Pallone F. Vasoactive intestinal polypeptide modulates the in vitro immunoglobulin A production by intestinal lamina propria lymphocytes. Gastroenterology. 1994;106:576-82.
438. Delgado M, Ganea D. Inhibition of IFN-gamma-induced janus kinase-1-STAT1 activation in macrophages by vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide. J Immunol 2000;Sep 15;165( 6): 051-7.
439. Sun W, Tadmori I, Yang L, Delgado M, Ganea D. Vasoactive intestinal peptide (VIP) inhibits TGF-beta1 production in murine macrophages. J Neuroimmunol 2000; Jul 10; 107( 1):88-99.
440. Xin Z, Sriram S, Vasoactive intestinal peptide inhibits IL-12 and nitric oxide production in murine macrophages. J Neuroimmunol 1998; Aug 14;89( 1-2):206-12.
441. Kawamura N, Tamura H, Obana S, Wenner M, Ishikawa T, Nakata A, Yamamoto H. Differential effects of neuropeptides on cytokine production by mouse helper T cell subsets. Neuroimmunomodulation 1998;Jan-Apr;5( 1-2):9-15.
442. Martinez C, Delgado M, Pozo D, Leceta J, Calvo JR, Ganea D, Gomariz RP. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide modulate endo-toxin-induced IL-6 production by murine peritoneal macrophages. J Leukoc Biol 1998;May;63( 5):591-601.
443. Tang H, Sun L, Xin Z, Ganea D. Down-regulation of cytokine expression in murine lymphocytes by PACAP and VIP. Ann N Y Acad Sci 1996; Dec 26;805:768-78.
444. Martinez C, Delgado M, Pozo D, Leceta J, Calvo JR, Ganea D, Gomariz RP. VIP and PACAP enhance IL-6 release and mRNA levels in resting peritoneal macrophages: in vitro and in vivo studies. J Neuroimmunol 1998;May 15;85( 2):155-67.
445. Delgado M, Ganea D. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit antigen-induced apoptosis of mature T lymphocytes by inhibiting Fas ligand expression. J Immunol 2000; Feb 1;164( 3):1200-10.
446. Taylor AW, Streilein JW, Cousins SW. Immunoreactive vasoactive intestinal peptide contributes to the immunosuppresssive activity of normal aqueous humor. J Immunol 1994;153:1080-1086.
447. Ferguson TA, Fletcher S, Herndon J, Griffi th TS. Neuropeptides modulate immune deviation induced via the anterior chamber of the eye. J Immunol 1995;155:1746-56.
448. Lundeberg L, Mutt V, Nordlind K. Inhibitory effect of vasoactive intestinal peptide on the challenge phase of allergic contact dermatitis in humans. Acta Derm Venereol 1999;May;79( 3):178-82.
449. Frontiers FB, editor. The Cytokine Network. In: Hames BD, Glover DM, series editors. Oxford in Molecular Biology Series University Press, 2000.
450. Grignani G. Maiolo, Cytokines and hemostasis. A Haematologica 2000;Sept;85( 9):967-972.
451. Warren JL. Type I cytokines, interferons and their receptors. In: Paul WE, editor. Fundamental Immunology, 4 th edition. Lippincott-Raven, 1999:741-74.
452. Krauker T, Vilcek J, Oppenheim JJ. Proinfl ammatory cytokines. In: Paul WE, editor. Fundamental Immunology 4th edition. Lippincott-Raven, 1999:775-811.
453. Mathison RT, Davison JS, Befus AD. Neuroendocrine regulation of inflammation and tissue repair by submandibular gland factors. Immunology Today 1994;14:527-532.
454. Berczi I, Chow DA, Sabbadini ER. Neuroimmunoregulation and natural immunity. Domestic Anim Endocrin 1998;15:273-281.
455. Sabbadini ER, Berczi I. Immunoregulation by the salivary glands. Biomed Rev 1998;9:79-91.
456. Befus D et al. Immunomodulation by the submandibular gland. In: Berczi I, Gorczynski R, editors. Neuroimmmune Biology: New Foundation of Biology. Shannon, Co. Clare, Ireland, Elsevier, 2001.
457. Sabbadini et al. Immunoregulation by glandular kallikrein. In: Berczi I, Gorczynski R, editors. Neuroimmmune Biology: New Foundation of Biology. Shannon, Co. Clare,
458. Ireland, Elsevier, 2001.
459. Brandtzaeg P, Farstad IN, Haraldsen G, Jahnsen FL. Cellular and molecular mechanisms for induction of mucosal immunity. Dev Biol Stand 1998;92:93-108.
460. Chen YH, Weiner HL. Dose-dependent activation and deletion of antigen-specifi c T cells following oral tolerance. Ann N Y Acad Sci 1996;Feb 13;778:111-21.
461. Davison J. The Salivary Gland Peptides: Their Role in Anaphylaxis and Lipopolysaccharide (LPS)-Induced Inflammation. In: Berczi I, Gorczynski R, editors. Neuroimmmune Biology: New Foundation of Biology.Shannon, Co. Clare, Ireland, Elsevier, 2001.
462. McDermott MR, Clark DA, Bienenstock J. Evidence for a common mucosal immunologic system. II. Influence of the estrous cycle on B immunoblast migration into genital and intestinal tissues. J Immunol 1980;Jun;124( 6):2536-9.
463. Nagy E, Berczi I. Pituitary dependence of bone marrow function. Brit J Haematol 1989;71:457-462.
464. Berczi I, Nagy E. Effects of hypophysectomy on immune function. In: Ader R, Felten DL, Cohen N, editors. Psychoneuroimmunology II. Academic Press 1991:339-375.
465. Bernard C. Lecons sur les phenomenes de la vie communs aux animaux et aux vegetaux. Balliere, Paris 1878.
466. Berczi I. Neurohormonal host defence in endotoxin shock Ann NY Acad Sci 830:787-802, 1998.
467. Berczi I, Bertok L, Chow D. Natural immunity and neuroimmune host defence..In:Ario Conti, Georges J.M. Maestroni, Samuel M. McCann, Esther M. Sternberg, James M. Lipton, Craig C., editors. Neuroimmunomodulation: Perspectives at the New Millennium. Ann
N Y Acad Sci 2000;917:248-57
468. Medzhitov R, Janeway C Jr. Innate immune recognition: mechanisms and pathways. Immunol Rev 2000;Feb;173: 89-97.
469. Berczi I. The stress concept and neuroimmunoregulation in modern biology. Ann NY Acad Sci 1998;851:3-12.
470. Berczi I. Neuroendocrine defence in endotoxin shock.
471. (A review). Acta Microbiol Hun 1993;30( 4);265-302.
472. Berczi I, Nagy E. Neurohormonal control of cytokines during injury. In: Rothwell NJ, Berkenbosch F, editors. Brain Control of Responses to Trauma. Cambridge University Press, 1994:32-107.
473. Berczi I. Neuroendocrine response to endotoxin. Ann NY Acad Sci 1998; 851: 411-415.
474. Haeryfar SMM, Berczi I. The thymus and the acute phase response. Mol Cell Biol 2001;47(1):145-56. Review.
475. Pittman QJ, Chen X, Mouihate A, Martin S. Vasopressin-induced atipyresis. Sex-and experience- dependent febrile response. Ann NY Acad Sci 1998;856:53-61.
476. McEwen BS. Allostasis, allostatic load, and the aging nervous system: role of excitatory amino acids and excitotoxicity. Neurochem Res 2000;Oct;25( 9-10):1219-31.
477. Anisman H, Baines MG, Berczi I, Bernstein CN, Blennerhassett MG, Gorczynski RM, Greenberg AH, Kisil FT, Mathison RD, Nagy E, Nance DM, Perdue MH, Pomerantz DK, Sabbadini ER, Stanisz A, Warrington RJ. Neuroimmune mechanisms in health and disease: 1. Health. Can Med Assoc J 1996;155( 7):867-874.
478. Gorczinsky R. Understanding classical conditioning of immune responses. In: Berczi I, Gorczynski R, editors. Neuroimmune Biology: New Foundation of Biology. Shannon, Co. Clare, Ireland, Elsevier, 2001.
479. Pomerantz D. Interactions Between the Immune and the Reproductive Systems. In: Berczi I, Gorczynski R, editors. Neuroimmune Biology: New Foundation of Biology. Shannon, Co. Clare, Ireland, Elsevier,2001.
480. Luheshi G. Leptin and Cytokines: Actions and Interactions in Fever and Appetite Control. In: Berczi I, Gorczynski R, editors. Neuroimmune Biology: New Foundation of Biology. Shannon, Co. Clare, Ireland, Elsevier, 2001.
481. Baines M. Olfactory Stimuli and Allo-Recognition. In: Berczi I, Gorczynski R, editors. Neuroimmune Biology: New Foundation of Biology. Shannon, Co. Clare, Ireland, Elsevier,2001.
482. Berczi I, Nagy E, Asa SL, Kovacs K. The influence of pituitary hormones on adjuvant arthritis. Arthritis Rheum. 1984;27:682-688.
483. Nagy E, Friesen HG, Sehon AH, Berczi I. Immunomodulation in rats by transplantable anterior pituitary tumors. Endocrinology 1985;16:1117-1122.
484. Nagy E, Berczi I. Immunomodulation by tamoxifen and pergolide. Immunopharmacology 1986;12:145-153.
485. I. Berczi I, Cosby H, Hunter T, Baragar F, McNeilly AS, Friesen HG. Decreased bioactivity of circulating prolactin in patients with rheumatoid arthritis. Brit J Rheum 1987;26:433-436.
486. Nagy E, Chalmers IM, Baragar FD, Friesen HG, Berczi I. Prolactin deficiency in rheumatoid arthritis. J Rheumatol 1991;18:1662-1668.
487. Ramachandra RN, Sehon AH, Berczi I. Neuro-hormonal host defence in endotoxin shock. Brain Behav Immun 1992;6:157-169.
488. Baral E, Nagy E, Berczi I. Target cells are sensitized for cytotoxic T lymphocyte mediated destruction by estradiol and tamoxifen. Int J Cancer 1994;58:64-68.
489. Baral E, Nagy E, Berczi I. Modulation of natural killer cell mediated cytotoxicity by tamoxifen and estradiol. Cancer 1995;75:591-599.
490. Anisman H., Baines MG, Berczi, Bernstein CN, Blennerhassett MG, Gorczynski RM, Greenberg AH, Kisil FT, Mathison RD, Nagy E, Nance DM, Perdue MH, Pomerantz DK, Sabbadini ER, Stanisz A., Warrington RJ. Neuroimmune mechanisms in health and disease: 2. Disease. Can Med Assoc J 1996;155( 8):1075-1082.
491. McCann SM, Lipton JM, Sternberg EM, Chrousos GP, Gold PW, Smith CC, editors. Neuroimmunomodulation: Molecular aspects, integrative systems, and clinical advances.
492. Ann NY Acad Sci 1998;830.
493. Csermely P, editor. Stress of life, from molecules to man. Ann NY Acad Sci 851: 1998.
494. Dickstein J, Moldofsky H. Sleep, cytokines and immune function. Sleep Medicine Reviews 1999; 3( 3) (in press).
495. S Rivest, S Lacroix, L Vallieres, S Nadeau, J Zhang, N Laflamme. How the blood talks to the brain parenchyma and the paraventricular nucleus of the hypothalamus during systemic inflammatory and infectious stimuli. Proc Soc Exp Biol Med 2000; 223: 22-38.
496. Jacobs LJ. Prolactin. In: Jaffe BM, Behrman HR, editors. Methods of Hormone Radioimmunoassay. Academic Press 1979:199-222

Disclaimer: "If you are experiencing any health problems, it is your responsibility to seek the advise of a licensed health care practitioner. The statements contained herein have not been evaluated nor endorsed by the FDA."